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clinical care. This spring will bring
renovations at McClellan Hall,
with completion in time for the
upcoming academic year. Funding
from the Foerderer Foundation 
is making it possible to transform
McClellan into a modern 250+ seat 
educational auditorium, with state-
of-the-art technology.
Other changes in the near future
will include:
•Constructing a 5-story academic 
building on the southwest portion
of Scott Plaza. This structure,
with underground parking, will
house another large auditorium,
the clinical skill assessment 
center, small group study space,
and additional classrooms and
meeting rooms. Groundbreaking
for the 2-year project is slated
for later this year.
•Converting the remainder of
Scott Plaza into a campus green.
This will lend a more typical
“university” feel to the campus and
allow an open view to Jefferson
Alumni Hall and the Bluemle Life
Sciences Building (BLSB).
•Building a new ambulatory care
facility for clinical practices at 
the corner of 10th and Sansom
Streets. This facility would
enable us to centralize physician
practices that are now scattered
throughout the campus.
• We also expect, in a later phase
of the construction plan, to add
up to 100,000 square feet of new
research space to the BLSB at 
the corner of 10th and Locust.
By design, the current Bluemle
Building contains the core 
building systems necessary to
accommodate this expansion.
Making these changes is about 
more than simply adding rooms or
reshaping our architectural footprint.
We seek a physical plan that fosters
a “community of scholars” – a
campus that encourages meeting
and co-mingling by all members 
of the Jefferson community. To 
further encourage this atmosphere
we are considering converting the
west side of the Scott Building’s
street floor to a café.
The space changes, and the entire
Strategic Plan, will go a long way
toward helping Jefferson’s students,
faculty, physicians, nurses, and other
healthcare professionals deliver first
rate patient care – and that’s what
TJU is all about.
Our timeline for the planning
process is aggressive. We have
already formed faculty working
groups around the major areas of
the plan and expect their reports in
April. After submitting the reports
to rigorous review by the President’s
Advisory Council, we will put
these reports before the University 
Board of Trustees in June. Over the 
summer, each college will work on
its own specific plan and help create
institution-wide recommendations
to form the final detailed University
Strategic Plan.
Throughout the planning process,
we will fix our view on the ultimate
goal: positioning Jefferson as a
national leader in medical education,
research, clinical care, and a multi-
disciplinary approach to healthcare.
This is the Jefferson you expect and
deserve. This is the Jefferson our
community, and the nation, needs.
Robert L. Barchi MD PhD
President
Thomas Jefferson University
Affecting virtually every
facet of the institution,
the University Strategic
Plan is the scaffolding
that will support our
rebuilding efforts to meet
21st century challenges 
in research, education,
clinical care, and space.
Plan is the scaffolding that will 
support our rebuilding efforts to
meet 21st century challenges in
research, education, clinical care,
and space. Each of these areas will
demand our collective energies and
test our commitment to change.
The most pressing and visible steps
will involve physical changes to the
campus to meet academic needs,
create a sense of “place,” and open
up sorely needed green space. But
this plan will also yield dramatic
changes in education, research, and
clinical care. For example:
•In education, we must expand to
become a comprehensive health
care university. This entails taking
full advantage of multidisciplinary 
opportunities, designing our 
educational programs to meet
tomorrow’s health care delivery
needs, increasing our use of 
educational technology, and 
promoting all the good things
TJU offers its students.
•In research,TJU must achieve
growth in a difficult funding cycle,
strengthen its translational and
clinical portfolio, and maximize
its collaboration as we have
done with the NIH roadmap.
•In clinical care,TJU must project
a stronger image of its clinical
excellence, promote its integrated
clinical practice, and identify the
key differentiating areas in which
to focus its clinical growth.
The physical changes will come
first but will herald the changes
ahead in education, research, and
University
Strategic Plan
– Defining the
Future of
Clinical Care
Robert L. Barchi MD PhD
In my Presidential Address last
October, I asked: “Who, when 
presented with Jefferson’s legacy,
would not jump at the opportunity
to continue to build on its 
outstanding record of science 
and service?” 
In writing to you, Jeff’s distinguished
alumni, I again recognize the great
privilege I have in leading Jefferson
at a momentous time in its history:
a period in which the university
will establish its place as a national
leader in defining the future of 
clinical care.
In the months ahead, the university 
community will be working closely
with TJUH to craft a strategic plan
that will position TJU as one of the
nation’s premier educators of health
care practitioners, a leading clinical
care innovator, and a major center
for patient-oriented research and
clinical trials.
Clearly, Jefferson has rested too
long on its time-honored laurels.
Our students, faculty, and community
deserve better – and so do you.
The time has come to restore the
university’s top ranking in general
medicine and research-oriented
medical education. The time has
come to renew Jeff ’s outstanding
reputation in faculty and student
recruitment, and in philanthropy.
At the same time, all of us must
maintain Jeff’s focus on leading-edge
patient care.
Affecting virtually every facet of the
institution, the University Strategic
Message 
from the President
The community of teachers and learners here, and those who have
come through Jefferson, is often called the Jefferson family, because
of the collaborative and caring environment that we value. This
perception is furthered by the loyalty of our employees, the support
of our alumni, and the long tenure of many of our faculty. 
As dean, I have the privilege of participating in medical
college life in a fashion unlike most others. Each August,
I have the honor of welcoming the next class of students
and their families. At the White Coat Ceremony, I see the
pride and excitement of parents and grandparents as
their offspring don the outward sign of our profession,
and the first phase of everyone’s dream has been fulfilled.
At Sophomore Parents Day, I again see families come
together to learn, and to celebrate successes. With the
help of the faculty, I launch the clinical phase of our
students’ education, speak with them about medical
errors, and preside over the delivery of the Match results and the
awarding of prizes on Class Day. I am the first to shake the hand of
these Jefferson physicians as they walk across the stage at
graduation, and I marvel as I share in the renewal of longstanding
bonds during Alumni Weekend each October. 
I share many other moments too with Jeffersonians and their
families. Births, baptisms, bar and bat mitzvahs, confirmations, and
marriages are milestones in the lives of our students, faculty, and
staff. I am privileged to be included in their happiness, to see their
families grow, their children excel, and their hearts fill with pride.
Like all families, Jefferson suffers losses. Over the past few months I
have been with Jefferson families at these most painful times, the
loss of a family member. I have been joined on these occasions by
numerous colleagues. Each of us has crossed the line from being a
physician-healer to being intimates within that particular circle of
life. In the latter role, we are helpless as healers. We cannot cure the
malady. We cannot resurrect the fallen. We cannot prevent
suffering. Our medical knowledge and skills are useless against the
pain felt by these people who are close to us. In these settings I
sense my own discomfort. I am accustomed to being able to help, to
make a difference with a physician's armamentarium of technology
and molecular insight. 
In our roles as physicians, we are comfortable with death, in the
sense of feeling intellectually in command of the facts, and able to
leave the setting after announcing the unwanted news. When we
are part of the family that is suffering loss, however, we are stripped
of everything that makes us physicians. It is of no use here. We are
not in control. We are participants engulfed in the grief. 
We stand by quietly, whisper words of condolence, and attempt to
support the grieving on their painful journey to acceptance. We are
thankful for the rituals of our individual religious heritage, as they
show us the way to navigate the storm, providing some comfort of
predictability during those difficult first days. We use the skills not
of our medical mentors, but of our mothers and fathers,
grandmothers and grandfathers. Those attributes that make us who
we are—not what we do—are what are needed in these moments of
despair. 
As I looked out over the sea of people at each of the 3 ceremonies I
have recently attended, I saw this humanity in the
hundreds of members of the Jefferson family in
attendance. They represented 3 different religious
traditions, 3 different ages, 3 unique losses that
paralyzed the hearts of those close to the fallen.  
In his book Man’s Search for Meaning, Frankl teaches us
much about our battle with despair in these settings.
We enter that “provisional state” where no meaning,
no goal of life, no clear direction is present. We cannot
fathom life without the one who has left this earthly
existence. We experience a state of existential vacuum,
“without a future and without a goal.” He shows us that there can
be meaning in suffering, although it is often hard to identify. He
also teaches us that the highest aspiration of the human soul is the
love of another. It is what draws us to each other, and it is what has
drawn most of us to the healing arts. 
We do function as healers when we gather with our family to
mourn, to validate loss and the importance of the lost one to us all,
and reaffirm that highest aspiration, to love others.
I bring this to you this month for 2 reasons. First, may all of us
celebrate, and keep in our thoughts and prayers those members of
the Jefferson family whom we have recently lost. We strive to
incorporate the goodness of their lives and the lessons that we
learned from them into our own personae as physicians, and as
humans. In this way, we can derive some meaning from the
seemingly senseless or capricious loss of a cherished life.  
Second, we must occasionally permit ourselves to lose the mantle
(and protection) of the title “physician,” so we can be “person” to
those who need us, for it is our humanity, not our physicianship,
that adds value to our presence at these difficult times. We must not
fear the exposure of our individual humanity. And we must teach
our students and residents to let their humanity and their
physicianship coexist and flourish. 
Jefferson is the kind of family where that degree of humanity is
nurtured, respected, and celebrated. A place where meaning can be
derived from suffering, and pain can be ameliorated in many ways.
Warmly,
Thomas J. Nasca ’75
Senior Vice President, Thomas Jefferson University
Dean, Jefferson Medical College
President, Jefferson University Physicians
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T H E D E A N ’ S  C O L U M N by Thomas J. Nasca ’75
The Circle of Life
7S H A P I N G  T H E  F U T U R E
The Alumni Bulletin devotes a column in each issue to introduce readers
to Jefferson’s junior faculty members (Instructor and Assistant Professor)
who are doing and publishing significant basic, translational, or clinical
research. All whose stories appear in this space were nominated for this
recognition by their department chairperson.
Carol M. Artlett PhD is a Research Assistant Professor in the
Department of Medicine, Division of Rheumatology. She was awarded
a PhD in the genetics of scleroderma in 1996 by the Royal Free
Hospital School of Medicine in London, triggering a deep interest in
understanding the pathogenesis of systemic scleroderma. The same
year Dr. Artlett and her husband relocated to Philadelphia so she
could work with Sergio A. Jimenez MD, the Dorrance H. Hamilton
Professor of Medicine and Professor of Biochemistry, a world
renowned expert in this disease. Dr. Artlett soon began investigating
the role of microchimeric cells in the pathogenesis of scleroderma
with research support from both the Scleroderma Foundation and the
Arthritis Foundation.
As a result of this investigation Dr. Artlett was awarded the Penn
State Hershey Finkelstein Award as well as the American College of
Rheumatology Larry Freeman Physician Scientist Award, and the
initial findings of her research were published in the New England
Journal of Medicine in 1998. Also in 1998, Dr. Artlett received a
‘FIRST’ award from the National Institutes of Health. Her research
has extended to other autoimmune diseases including males with
juvenile idiopathic inflammatory myopathies and she has been able to
demonstrate that these patients have cells from their mothers in the
muscle lesions. A collaborative project in which Dr. Artlett is
involved is investigating the hypothesis that some dietary supple-
ments can reduce the collagen expression of SSc fibroblasts which
may be susceptible to modulation through the glucose pathway.
Some of Dr. Artlett’s future goals include investigating the activation
of microchimeric cells to determine if they are involved in disease or
are just inflammatory markers of disease. She plans to learn more
about the allograft inflammatory factor-1 (AIFI), a newly identified
gene which she and others showed is expressed in scleroderma. Dr.
Artlett also is interested in the role of dendritic cells in the
pathogenesis of scleroderma. To date, she has been the principal
investigator on 5 funded research grants and lead author on 11 of her
34 published articles.
James G. Zangrelli ’88, an Assistant Professor of Medicine at
Jefferson, has a special interest in asthma. His research focuses on the
mechanisms by which the survival of inflammatory cells in the
asthmatic pathway are regulated. Dr. Zangrelli points out that
Jefferson is one of only a few centers in the country using a relevant
human model of airway inflammation.
In this model, an isolated area of a lung is “challenged” with pollen
by using a bronchoscope and cells and secretions are sampled over
time for analysis. It is believed that this approach will help
researchers identify the mechanisms by which the survival of inflam-
matory cells in the asthmatic airway is regulated. Once these
mechanisms are understood, Dr. Zangrelli believes it will be possible
to develop novel treatment strategies for patients with asthma and
rhinitis. He and his colleagues also are involved in characterizing and
studying patients with severe asthma according to their airway
physiology, inflammation, genetics, and racial characteristics.
Between 1994 and 1999, Dr. James Zangrelli was awarded a Merck
Young Investigator Award, an Allen Hamburgs Pulmonary
Fellowship, a Parke B. Francis Fellowship, and an American Lung
Association research grant. Since 1995 his pulmonary research has
been supported by 6 awarded grants, including a National Institutes
of Health training grant. Zangrelli has 22 publications in peer
reviewed journals and has contributed 7 book chapters in his field of
interest. To date, he has spoken about his results at 22 venues around
the country. TJU
G I F T  O F  L E A R N I N G
Scholarship Honoring Paul Brucker Is
Established by Stratton Family Foundation
Paul C. Brucker MD, who stepped down September 1
after 14 years as President of Thomas Jefferson
University, has been specially honored by James W.
Stratton and the Stratton Family Foundation, which
established a scholarship in his name to support
students in the accelerated BA/MD program of
Pennsylvania State University and Jefferson Medical
College. Mr. Stratton is a longtime University Trustee
and past Chairman of the Board. The establishment
ceremony included remarks by Dean Thomas Nasca ’75
and President Robert L. Barchi MD PhD, who praised
Dr. Brucker’s strong advocacy for outstanding clinical
education—a top priority at Jefferson.
Dean Nasca, Dr. Brucker, Mr. Stratton, and Pres. Barchi
Using Shaped Beam
Surgery to Sculpt
Therapy for Hard-to-
Reach Brain Tumors
In contrast to traditional surgical techniques,
neurosurgeons and radiation oncologists at
Jefferson are using a new type of advanced
radiation technology to “surgically” treat a
wide range of tumors in the brain and spine,
curing tumors that they couldn’t treat before.
The new technology, called shaped beam
surgery, can mold radiation beams to fit the
exact size and shape of a tumor. Jefferson is the
only medical center in the Delaware Valley that
offers it, and one of only a few centers in the
nation. 
“Shaped beam surgery is a huge advance in
treating both benign and malignant tumors in
the brain and the spinal cord regions,” says
neurosurgeon David Andrews MD, Professor
and Director of the Division of Neuro-
oncologic Neurosurgery and Stereotactic
Radiosurgery. So far, the new technology has
mostly been used against benign tumors in the
brain. “We are curing benign tumors we
couldn’t treat before,” he says, and as a result,
“often restoring vision and hearing if tumors
involve these functions.
“Shaped beam surgery gives us infinite
flexibility to deal with lesions from the top of
the head to the bottom of the spine. We can
wrap doses around structures such as the spinal
cord, and can create a very high dose of
radiation while leaving the cord untouched.
There’s no other technology out there that can
do this.”
The new technology enables specialists to focus radiation more
precisely on specific targets while leaving healthy tissue virtually
untouched, holding great therapeutic promise for hard-to-reach and
difficult-to-treat tumors, including meningiomas, pituitary tumors,
recurrent brain tumors, spine tumors, and acoustic tumors. Shaped
beam surgery relies on computers to develop and carry out a
treatment plan that includes tailoring the shape and intensity of the
radiation beams to fit the exact size of the tumor, while sparing
healthy tissue. 
A recurrent challenge in radiosurgery is to position the patient
properly for radiation treatment. The new technology overcomes
this in part by rotating around the patient, constantly editing the
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beams of radiation and adapting the shape of the beam to the shape
of the tumor, in order to supply exactly what is needed at any angle.
The preparation begins with x-rays that are taken to locate the
tumor. Then, along with results from a CT scan, a computer
program calculates to the millimeter the best position for treating
the patient’s tumor. A computer-guided treatment couch then
positions the patient—and repositions him or her as
necessary—moving the individual’s tumor into exactly the position
needed to receive radiation. Treatment planning that might take
hours, if not days, can be reduced to minutes. “This is important
because many tumors are irregularly shaped, and we want to spare
healthy tissue,” notes Maria Werner-Wasik MD, Associate Professor
and Director of Radiation Oncology within the radiosurgery
program.
Radiation oncologist Maria Werner-Wasik MD and neurosurgeon David Andrews MD
N E U R O S C I E N C E  A N D  N E U R O S U R G E R Y
9Converting Adult Human Stem Cells to
Longer-Lasting Dopamine Neurons
Jefferson researchers have found a new way to coax bone marrow
stem cells into becoming dopamine-producing neurons. If the
method proves reliable, the work may ultimately lead to new
therapies for neurological diseases such as Parkinson’s disease,
which is marked by a loss of dopamine-making cells in the brain.
Developmental biologist Lorraine Iacovitti PhD, Professor of
Neurology and Associate Director of Jefferson's Farber Institute for
Neurosciences, and her colleagues had previously shown that by
using a potion of growth factors and other nutrients in the
laboratory, they were able to convert adult human bone marrow
stem cells into adult brain cells. Human adult bone marrow stem
cells—also known as pluripotent stem cells—normally give rise to
human bone, muscle, cartilage, and fat cells. 
While nearly all cells in her experiment, after conversion, looked
like neurons with axonal processes, they invariably reverted back to
their original undifferentiated state in 2 to 3 days. Dr. Iacovitti and
her colleagues instead attempted to grow the cells in a different
way. Rather than an attached monolayer of skin-like cells, they
grew the bone marrow cells in suspension as neurospheres—groups
of cells early in development—akin to the way neural stem cells are
grown. 
They found that the newly differentiated cells didn’t merely look
like dopamine neurons, but expressed traits of neurons and related
cells called astrocytes and oligodendrocytes—cells derived from
neural stem cells. What’s more, the neurons produced tyrosine
hydroxylase, an enzyme needed to make dopamine. 
The Jefferson scientists also found a 2nd enzyme involved in
dopamine production, and an important molecule called the
dopamine transporter. 
Interestingly, Dr. Iacovitti notes, some of the cellular markers that
would be expected to be expressed by new bone marrow cells were
While it’s still early in its use, Dr. Andrews notes that there is
evidence that the technology is already helping improve survival
for individuals with the usually deadly brain tumor, glioblastoma
multiforme. Preliminary data show that patients’ median survival
time has improved from 12 to 19 months. 
The new technology will not replace Jefferson's on-site Gamma
Knife, which is used in many similar ways for treating difficult-to-
reach areas of the brain. The Gamma Knife is more likely to be
used when the individual patient’s tumor requires targeting a very
high dose of radiation at a very specific point in the brain. The
Gamma Knife is static, whereas shaped beam surgery is dynamic.
“Shaped beam surgery does everything the Gamma Knife can do
and more,” Andrews says, including treatments for various types of
tumors, epilepsy, trigeminal neuralgia, and even, in some cases,
obsessive compulsive disorder and movement disorders. TJU
New Evidence Helps Explain Statins’
Effects in Alzheimer’s Disease
Scientists at Jefferson’s Farber Institute for Neurosciences have
taken another step in understanding the potential effects of anti-
cholesterol drugs on Alzheimer’s disease. They have identified a
biochemical pathway that affects the activity of statins, particularly
their ability to break down an early form of the protein amyloid that
clusters and forms sticky plaques in the brain, creating Alzheimer’s
disease. The results may eventually help provide new targets for
anti-amyloid drugs to help treat the disease.
Some epidemiological studies have found a link between people
taking statin drugs to lower blood cholesterol and a lower incidence
of Alzheimer’s. Statins work by inhibiting an enzyme involved in
cholesterol production, and currently are being tested in clinical
trials for their possible effects in slowing the progression of
Alzheimer’s.
In a series of experiments, Steve Pedrini PhD, a postdoctoral fellow
in neurology, and his colleagues found evidence suggesting that an
enzymatic pathway called Rho/ROCK may play an important role in
the metabolism of APP, which is an early form of amyloid, and in
turn, affect the ability of statins to break down a form of APP. “It’s
particularly important to understand the pathways involved in
Alzheimer’s, in order to find more specific therapies,” Dr. Pedrini
says.
“This reveals an unsuspected pathway linking statins and amyloid
metabolism,” notes Sam Gandy MD PhD, Director of Jefferson's
Farber Institute. “This may help unravel statin action in Alzheimer’s
as well as point the way toward novel anti-amyloid drugs.” TJU
present in bone marrow stem cells grown in the original
monolayers, though they were fewer in number. “The markers
don’t disappear. The cells seem to have markers of both bone
marrow cells and dopamine neurons all the time. They don’t
forsake what they normally would be.”
While she can’t say for sure whether or not the stem cells grown
with the new method have markers of both bone marrow stem cells
and dopamine neurons, the new dopamine neurons did not revert
back to stem cells.
“There are limitations to differentiating adult stem cells the way we
want them—to get them to permanently give up being what they
were meant to be and become neurons. Maybe this is a way to grow
these stem cells to get them to truly become dopamine neurons
instead of just looking like neurons.
“If we can now appropriately direct the differentiation of bone
marrow stem cells, these cells could provide an abundant source of
adult human neurons for use in the treatment of neurodegenerative
diseases.” TJU
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Liver Transplant: 
Less Rejection, Better Survival 
with New Drug Regimen
Transplant surgeons at Jefferson have found that a new combination
of drugs results in fewer incidences of rejection in liver transplant
patients than do current treatments. Led by Ignazio Marino MD,
Professor and Director of Liver Transplantation and Hepatobiliary
Surgery, the team analyzed the results of 50 liver transplant
procedures they performed over the course of 3 years. To try to
prevent or lessen the severity of rejection, Dr. Marino’s group used a
monoclonal antibody, basiliximab, as part of a group of drugs that
included tacrolimus, a standard anti-rejection agent, and low doses of
steroids. Basiliximab, which ties up an important immune system cell
(IL-2) receptor, has been used for kidney transplantation.
The group found a much lower incidence of liver rejection. “When
we added basiliximab, the rate of rejection dropped dramatically to
12 percent,” says Dr. Marino. He notes that the rate, which is after
one year, is comparable to a French study that showed that 38
percent of patients had a rejection episode in the first year. Another
trial conducted by the University of Pittsburgh had a 45 percent
rejection rate after one year. “The big advantage [of this combination
of drugs] is that the incidence of rejection is significantly decreased,”
he says. “These results could change the standard of care for liver
transplant recipients.”
The results show that the drugs may have helped improve survival as
well. Of the 50 patients who received transplants, 88 percent were
alive 3 years later (the actuarial survival rate at 3 years was 88
percent). According to the Transplant Liver Registry of the United
Network for Organ Sharing, approximately 78 percent of those who
receive liver transplants live for at least 3 years. Dr. Marino notes that
in the past 15 months of using this combination of drugs for liver
transplants at Jefferson, the one-year patient survival is 100 percent.
In the 1990s at the University of Pittsburgh, surgeons developed a
tacrolimus-based drug combination that changed the face of liver
transplantation. Its use greatly decreased the reliance on steroids,
which can produce nasty side effects, but high doses of the drug
caused neurotoxicity and kidney toxicity. In the last decade, surgeons
began using antibodies that were given to the patient initially before
surgery in an attempt to reduce side effects from high doses of
tacrolimus.
Tacrolimus is a drug that suppresses the immune system by
inhibiting an enzyme (calcineurin) crucial for T-cell proliferation,
which is important in the immune process. The Jefferson surgeons’
trial marks the first time anyone had evaluated the effectiveness and
safety of basiliximab and tacrolimus to suppress the immune system
to prevent the body’s rejection of a liver. “We think we have much
less toxicity in the short term because we use less tacrolimus,” he
says. They expect less toxicity in the long term as well, because they
used fewer steroids. As a result, he says, they expect fewer of the
complications associated with long term steroid use, which can
include hypertension, osteoporosis, and diabetes.
Dr. Marino has also discovered that basiliximab may affect hepatitis C
virus (HCV) recurrence. “We also suspect that the recurrence of HCV
is lower, though we don’t have enough data to confirm this,” he says.
Typically, immunosuppressed liver transplant patients experience
high rates of HCV recurrences, Dr. Marino notes, because the virus
has fewer restrictions on its growth. Perhaps, he says, the anti-IL2
monoclonal has some mechanism affecting the replication of the
HCV.
“If this observation can be confirmed, it’s important news because 60
percent of the patients we transplant are diagnosed with HCV. This
would mean an immunosuppression that can delay the recurrence of
HCV, on top of having fewer episodes of rejection and toxicity than
before.”
While Dr. Marino says that he would like to continue to investigate
whether these drugs indeed reduce the recurrence of HCV, he has
another clinical trial in mind. “We would like to begin a new study
with no steroids—just 2 doses of this new drug at the time of the
liver transplant and then tacrolimus for life.
“We think in the long term, we need to shift the paradigm of immune
suppression,” he says. “We may someday be able to wean patients
away from immune suppression.” TJU
Translational Research: 
Gene Therapy Rescues Failing Hearts 
in Lab Animals
Heart researchers at Jefferson Medical College have used gene therapy
to bring failing rat hearts back to normal. Scientists led by Walter
Koch PhD, Director of the Center for Translational Medicine, used a
virus to insert the gene for a protein called S100A1 into failing rat
hearts. “In contrast to other gene therapy strategies geared to overex-
pressing a gene,” says Dr. Koch, who is the W.W. Smith Professor of
Medicine, “because this protein is reduced in heart failure, simply
bringing the protein level back to normal restored heart function.” 
S100A1, which is part of a larger family of proteins called S100, binds
to calcium and is primarily found at high levels in muscle, particu-
larly the heart. Previous studies by other researchers showed that the
protein was reduced by as much as 50 percent in patients with heart
failure. A few years ago, Dr. Koch and his colleagues put the human
gene that makes S100A1 into a mouse, and found a resulting increase
in contractile function of the heart cell. The mice hearts worked
better and had stronger beats. 
Dr. Koch’s Jefferson team now examined whether the gene could
make failing hearts normal again. Twelve weeks after they had
simulated a heart attack in the rats, the researchers delivered the
human S100A1 gene to the heart through the coronary arteries by
injection of a genetically modified common cold virus as a carrier.
After about a week, they found the hearts began to work normally. In
addition, the animals’ heart muscle showed improved efficiency in
using its energy supply, which had been decreased in heart failure.
F I N D I N G S
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According to Dr. Koch, the improvements were seen in both the
whole animal as well as in individual heart cells. 
“This is one of the first studies to do intracoronary gene delivery in a
post-infarcted failing heart,” he says. “This proves it could actually
be a therapy since most of the previous studies of this type are
aimed at prevention—giving a gene and showing that certain heart
problems are prevented. In those cases, heart problems are not
actually reversed. This is a remarkable rescue and reversal of cardiac
dysfunction, with obvious clinical implications for future heart
failure therapy.”
Close to 5 million Americans have heart failure and more than
400,000 new cases are diagnosed each year. While the overall death
toll from heart disease has declined, the number of people dying
from chronic heart failure continues to rise. For example, the death
rate from coronary heart disease dropped 49 percent between 1970
and 1990, while deaths due to heart failure increased 64 percent
over that period.
“We have a unique molecule necessary for normal heart function,”
Dr. Koch says, noting that animals lacking the gene for S100A1 are
seemingly healthy until they are subjected to cardiac stress, after
which they usually die. The animals in the current study that
received the gene transfer were fine.
Next, he and his colleagues hope to learn more about the
mechanisms behind S100A1’s actions, and eventually, develop gene
therapy protocols in humans. S100A1 is also found in the cell’s
energy-producing mitochondria, he notes. He thinks the protein
may be a link between energy production and calcium signaling in
the heart cell—a crucial part of the process that makes the heart
beat. TJU
A Potential Trigger of Diabetic 
Kidney Disease
Scientists at Jefferson and at Mount Sinai School of Medicine have
identified a protein that plays a leading part in triggering kidney
disease in diabetic patients—the condition known as diabetic
nephropathy and the leading cause of kidney failure worldwide. The
finding could lead to the development of compounds that might be
used to treat diabetic kidney disease. 
According to study coauthor Kumar Sharma MD, Director of
Jefferson’s Center for Diabetic Kidney Disease, more than 40 percent
of patients with end-stage chronic kidney disease also have diabetic
nephropathy. While diabetic nephropathy affects approximately one
in 3 people with type 1 and type 2 diabetes, how diabetes damages
the kidneys is poorly understood. 
Dr. Sharma, along with Erwin Böttinger MD of Mount Sinai School of
Medicine in New York and their coworkers, studied kidney samples
from mice and people with and without diabetes and looked at the
effects of high glucose on the kidney cells. The researchers found that
a protein called CD36 was present in a specific cell type called the
proximal tubular epithelial cell in human diabetic kidney disease. In
humans, the cells seem to be involved in a self-directed cell death or
apoptosis in diabetic kidney disease. 
“We think CD36 might be a switch that is turned on in the human
condition, and might be one of the reasons these cells die in human
disease and start a cascade of progressive kidney failure,” Dr. Sharma
explains. “If we can develop compounds to block CD36, it could
potentially be a clinical intervention. 
“Our thinking is completely novel—that CD36 is a key player in
causing progressive diabetic kidney disease,” he says. “We think as
the diabetic kidney gets damaged, more and more of these proteins
and free fatty acids go through the urine and hit these tubular cells.
The tubular cells, via CD36, take them up and start the apoptosis
pathway and ultimately cause fibrosis and progressive kidney failure
as a result. We found almost all of the apoptotic cells had CD36 in
them. If we block CD36 in cell culture, these proteins and free fatty
acids don’t cause apoptosis.” 
Next, the researchers would like to develop a mouse model that
overexpresses CD36. “By increasing CD36 levels, we’d like to find out
if this does cause the apoptotic pathway with coexisting diabetes,”
Dr. Sharma says. He adds that there is some evidence showing that
CD36 might be involved in vascular damage in diabetes and lead to
atherosclerosis.  
Dr. Sharma currently is evaluating how a new medicine may reduce
scar tissue in damaged kidneys. “The goal of this study—which is the
only one of its kind in the United States—is to evaluate the extent to
which a new compound, called pirfenidone, can prevent the kidney
scarring that often results from diabetes,” he says. 
Kidney scarring results from the excessive activity of a molecule
called transforming growth factor-beta (TGF-beta). In previous
studies, Dr. Sharma’s research group found that TGF-beta stimulates
overproduction of the scar tissue in the kidneys of diabetic patients
and prevents normal kidney function. The new drug, pirfenidone,
was shown to block the damaging effects of TGF-beta. “This trial will
help us is to see if an antifibrotic approach will add to the armamen-
tarium for arresting diabetic nephropathy.” TJU
Zinc May Help Prevent 
Esophageal, Oral Cancers
Cancer researchers at Jefferson’s Kimmel Cancer Center have found
that zinc treatment may help prevent esophageal and oral cancers in
those individuals at high risk. Oral and esophageal cancers are
associated with nutritional zinc deficiency, and a rise in the
expression of the enzyme COX-2 is connected with these cancers.
Louise Fong PhD, Assistant Professor of Microbiology and
Immunology, and her colleagues have found that zinc given orally to
zinc-deficient rats reverses the development of precancerous
conditions in the esophagus and tongue and reverses the high
expression of COX-2 there as well.
continued on page 15
G I F T  O F  L E A R N I N G
Clinical Skills Center 
Named For Dr. and Mrs.
Robert D. Rector ’48 
President Robert L. Barchi MD PhD formally dedicated the Dr. and
Mrs. Robert D. Rector ’48 Clinical Skills Center at 833 Chestnut
Street in February. Family and friends of Dr. and Mrs. Rector,
faculty, students, and the center’s standardized patients gathered to
mark the occasion. Jefferson recently received a $10 million
bequest from the estate of Dr. and Mrs. Rector in support of the
center. 
Dean Thomas Nasca ’75 expressed his appreciation for the
generous bequest. “The foresight and generosity of Dr. and Mrs.
Rector will provide generations of Jefferson medical students with
state of the art clinical education and evaluation and permit
Jefferson faculty to conduct research in clinical skills education,”
Nasca observed. “Jefferson will be a national leader in the
continued production of outstanding clinicians, and in the identifi-
cation of educational and evaluative tools in the education of
tomorrow’s physicians.”
S i m u l a t i n g  a  C l i n i c a l  S e t t i n g
The Clinical Skills Center, directed by Katherine Worzala MD,
offers key components of a Jefferson medical education. Students
use computerized mannequins to become familiar with a variety of
pulses, heartbeats, and murmurs, and practice lifesaving
techniques such as placement of an IV, central line, or breathing
tube. Students learn to conduct an Objective Structured Clinical
Examination (OSCE) in cooperation with standardized patients—
actors who are trained to present a set of symptoms commonly
seen in clinical settings.
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• Renato Baserga MD has received the 2004 Scientific
Achievement Award from the American Cancer Society, an award
that is given annually to those who have made extraordinary
efforts in research. Dr. Baserga, a Professor of Microbiology and
Immunology at Jefferson, broke new ground with his kinetic cell
research in the mid 1950s, and was one of the first to publish the
cell kinetics of a tumor in 1960. In addition to his research, 
Dr. Baserga has been an active editor and associate editor of
numerous scientific journals. 
• Ronald E. Myers DSW PhD was presented with the American
Cancer Society’s Cancer Control Award. Dr. Myers is a Professor
of Medicine and directs the Division of Behavioral Epidemiology
in the Department of Medicine at Jefferson Medical College. Early
in his career, Dr. Myers concluded that colon cancer screening
and the appropriate follow-up of abnormal colon cancer screening
results could have notable impact on cancer survival, during a
time when early detection was not on the forefront of healthcare
issues. This drove Dr. Myers to focus his attention on educational
interventions to promote colon cancer screening. 
For the last 5 years, he has led the Access to Clinical and
Educational Studies project. Its aim is to develop a cancer
education and research network in the Philadelphia area that
links leaders of community organizations, community based
health care providers, volunteers, and advocates with cancer
researchers and cooperative oncology groups.
• Walter J. Curran Jr. MD, Chair of the Department of Radiation
Oncology and Clinical Director of Jefferson’s Kimmel Cancer
Center, has been awarded honorary membership in the European
Society of Therapeutic Radiology and Oncology. This honor
recognizes Dr. Curran’s contributions to clinical research through
his leadership of the Radiation Therapy and Oncology Group
(RTOG), a National Cancer Institute-funded cancer clinical trials
group headquartered in Philadelphia that carries out multidisci-
plinary cancer research throughout the United States and Canada.
Dr. Curran was recently reelected to his third 4-year term as
Group Chair of the Radiation Therapy Oncology Group (RTOG),
a Philadelphia-based federally funded cancer clinical trials group
that carries out multidisciplinary research nationwide and in
Canada.
As Group Chair, Dr. Curran serves as chief scientific leader of
the organization, as well as administrator. He also is principal
investigator of 2 major National Cancer Institute-funded grants
awarded to RTOG to support a number of clinical trials, in
addition to the organization’s Community Clinical Oncology
Program (CCOP). CCOP provides communities with the latest
cancer prevention and treatment research findings through partic-
ipation in clinical trials.
Dr. Curran, one of only 4 Group Chairs in the organization’s 35
years of existence, looks forward to his role. “RTOG continues to
conduct landmark trials and establish new standards of care for
brain tumors and for cancers of the head and neck, lung, gastroin-
testinal tract, and prostate,” says Dr. Curran. “The coming years
will be exciting.”
• The Greater Philadelphia Bioinformatics Alliance (GPBA) has
chosen a Jefferson student as one of 2 winners of the BioAdvance
Fellow Award in Bioinformatics. BioAdvance is launching this
new fellowship program to support innovative researchers in the
region, and will award $35,000 to each of 2 graduate students in
bioinformatics and computational biology. Rishi Lee Khan is a
joint degree candidate at Jefferson working towards a cross-
disciplinary PhD in electrical and computer engineering and
pathology, anatomy, and cell biology. Rishi’s research focuses on
linking in vivo physiology to microarray-based gene expression
analysis, and novel data analysis approaches to better understand
how neurons adapt to acute hypertension. It is expected that the
approach will lead to insights into receptor-driven neuronal
adaptation. TJU
Dean Nasca, Jack Weber (nephew of Dr. and
Mrs. Rector), Joan Hodkinson (niece) with
daughter Kate, President Barchi, and Dr.
Worzala
1 3
“If we train them to be masterful clinical skills people, they will
come back to that again and again throughout their careers. It’s
the one common denominator in every physician,” says Dale
Berg MD, Director of the Clinical Skills Curriculum.
In the future Jefferson will train medical, nursing,
and health professions students to work in
teams in simulated emergency and operating
rooms—just as they will in actual clinical
settings. Beginning with groundbreaking in
the fall of 2005, a new building will rise in
the plaza between the Scott Building and
Alumni Hall. 
T h e  G o o d  D o c t o r
In the community of Chambersburg, PA, Bob
Rector was known as “The Good Doctor.” After
graduating from Dickinson College and then from
Jefferson Medical College in 1948, Dr. Rector served his
internship at the Philadelphia Naval Hospital. He completed
residencies and fellowships at Good Samaritan Hospital,
Cincinnati, OH, and the Veterans Administration Hospital in
Saginaw, MI. He served aboard the U.S.S. Valley Forge as a general
surgeon and was chief of surgery at the VA Hospital in Saginaw.
In 1961, Dr. Rector joined the staff of Chambersburg Hospital,
where he served with distinction for 40 years.
Dr. Rector’s lifelong commitment to the health of the citizens of
the Chambersburg area was shared by his wife Dorothy, a
registered nurse who devoted herself to running his one-man
surgical practice for 40 years without outside help or even a
computer. Dr. Rector would perform surgery on Monday,
Wednesday, and Friday. On Tuesday, Thursday, and Saturday, he
would see patients in his office. It is estimated that he performed
more than 40,000 surgical procedures during his career and often
saw up to 60 patients each day in his office.
“Dorothy was at his side in everything he did. She
sacrificed a lot to promote his career,” says Jack
Weber, a nephew. “The 2 of them dedicated
their lives to the well-being of the
community. In addition to managing her
husband’s practice, she took care of day-
to-day living so that he could concentrate
on his patients.” 
Dr. Rector was greatly respected by his
fellow physicians, who often called upon
his skills when faced with a difficult
surgery. Said one colleague, “I truly think
that he was one of the most brilliant surgeons
I have ever met. Dr. Rector had that gift from
God. You either have it or you don’t—and he just
had it.”
The son of a minister, Dr. Rector grew up in a regimented
household where rules were strictly enforced. As a physician, he
resolved to never keep his patients waiting and to always go the
extra mile to meet their needs. Dr. Rector’s no-nonsense approach
appealed to patients, although his bedside manner could be
gruff—especially if the individual was not following his instruc-
tions.
Jack Weber says, “My aunt and uncle would be thrilled to know
that everything they hoped for is going to take place at Jefferson as
a result of their bequest. My uncle was very impressed with the
education he received at Jefferson and wanted to make sure that
today’s medical students had the same advantages.” TJU
Taking to the Skies to Provide 
Full Medical Transport Services
Thomas Jefferson University Hospital and JeffSTAT, Jefferson’s
ground medical transportation service, now provide air medical
transport services, making it the only all-inclusive provider of ground
and air medical transportation in the Philadelphia region. 
JeffSTAT will operate an EC 135, single pilot, twin-engine,
instrument-equipped helicopter capable of traveling at speeds up to
150 mph and owned by Air Methods of Englewood, Colorado, the
largest provider of medical helicopter services in the world. JeffSTAT,
a part of Thomas Jefferson University Hospital, has been providing
medical transportation services to the Delaware Valley since 1988.
Jefferson Hospital transports approximately 400 patients annually by
air and has relied on outside helicopter services in the past. But this
new service will provide Jefferson, its physicians, and patients with
dedicated air transportation. Most of the patients transported to
Jefferson Hospital by air require treatment for aneurysms and cerebral
hemorrhages, under the care of a skilled neurosurgeon, as well as for
stroke, spinal cord injury, trauma, and cardiac care.  
While most helicopter services are unable to operate during adverse
weather conditions, JeffSTAT is able to safely provide transportation
via ambulance. The availability of both ground and air transportation
from one source will also make it easier for hospitals and physicians
to coordinate services, because they will not have to rely on 2
separate companies. The helicopter is based at a heliport on
Columbus Boulevard on the Delaware River in Philadelphia, and is
available 24 hours a day for both inter-hospital transports and on-
scene trauma transports. A flight paramedic, flight nurse, and pilot
are based full time at the heliport. The helicopter can accommodate
up to 2 patients. Jefferson supplies the medical crew, consisting of
critical care transport nurses and paramedics, medical direction for
the program, training, and medical oversight. TJU
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Since our last report to the alumni, Peter V. Scoles ’70 of Philadelphia
joined the University Board of Trustees as an Alumni Trustee,
replacing Stephen Slogoff ’67 of Chicago.
Dr. Paul Brucker, after 14 years of distinguished service as President
of Thomas Jefferson University, stepped down in September 2004. He
will continue to teach medical students in a new learning center
named for him on the 2nd floor of the College Building. In a fitting
tribute to Dr. Brucker, the Scientific and Academic Affairs Committee
reported that 90 percent of current students at Jefferson would
recommend Jefferson to potential applicants. 
The Presidential Search Committee of the Board of Trustees selected
Robert Barchi MD PhD, former Provost of the University of
Pennsylvania, as Dr. Brucker’s successor. A Philadelphia native, Dr.
Barchi is a neurologist and molecular neuroscientist with a strong
research background, having had his lab supported by nearly 30 years
of continuous NIH funding. 
Dr. Barchi, at his first meeting, advised the board that he plans to
bring in consultants to advise him on an academic plan, a business
plan, and a development plan, including potential and costs. They
will have a response date of June 2005.
President Barchi also proposed 1) a complete review of all buildings
and their uses and needs (he noted that some of Jefferson’s
educational facilities are outdated and need to be improved in order
to attract the best students to Jefferson), 2) converting the university
to a 3 to 5 year budgeting process with rolling projections and more
robust planning mechanisms, and 3) developing a better framework
for strategic relationships between Thomas Jefferson University and
other academic institutions and city and state entities. 
He also noted that Jefferson needs to continue growing its research
programs, particularly translational research. These activities are
critical for recruiting nationally known faculty and the brightest
students. He believes Jefferson should maintain its current level of
basic research while targeting Jefferson’s traditionally strong areas of
clinical research for additional growth. These include cancer biology,
neuroscience, and cardiology. At present, Jefferson’s research profile
is not optimally balanced because more than half of the research
dollars are spent on basic science. Compared with other medical
universities, Jefferson conducts relatively little clinical research, a
situation that must be rectified.
President Barchi also told the board that he and Dean Nasca are
leading Jefferson’s senior medical faculty through a strategic planning
program designed to secure Jefferson’s status as a nationally
recognized health care university. He reminded the board that
Jefferson holds a unique position in medical education: Jefferson is
known as the place you want your family doctor, your specialist, and
your residents to be from, regardless of specialty, and regardless of
where in the country you live. Jefferson is known as a university that
educates outstanding clinicians. Jefferson will focus its efforts on
preparing clinicians who are prepared to be the best in whatever
discipline they enter, and to be clinical leaders wherever they
practice. 
This goal must not only be maintained but improved upon. It will be
Jefferson’s challenge to define the standard of clinical care in this
country in the 21st century. This will require a solid financial
position and investment in medical education and research—and
increased contributions from alumni, alumnae, and friends of
Jefferson.
President Barchi told the Board of Trustees that Jefferson is ideally
prepared to turn its dream into reality. “We have all the elements of
first rate health care delivery on one compact campus. We are ideally
configured to pursue a future of integrated health care. A future in
which many more people in this country will have access to quality
primary care and preventive medicine. A future in which we redefine
the education we provide for doctors, nurses, and other health profes-
sionals. A future in which we recognize that collaboration in research
can produced remarkable results that would have been impossible
otherwise. A future in which we maximize the impact of these
advances on all levels of our society.” 
Charles J. Stahl III ’56
Nancy S. Czarnecki ’65
Peter V. Scoles ’70
As the alumni know, the cost of providing a medical education to our
students far exceeds the tuition and state appropriation that Jefferson
Medical College receives each year. The practice of medicine is
economically challenging, at best. Thus, the clinical faculty now
struggle to support themselves financially, while providing their time
to educate medical students, residents, and fellows. The basic science
faculty are increasingly supporting themselves through research
grants, while providing their time to educate medical and graduate
students. Jefferson's facilities are aging, and the costs of maintenance
of the physical plant are high. Your annual undesignated contribu-
tions are used solely to support the academic infrastructure for our
educational programs. They are essential as we face the constantly
escalating costs of providing the kind of education that Jefferson
stands for.
So please be generous. Any gift, no matter how small, is appreciated
and valued.
To Make Your Annual Giving Contribution, 
Simply Clip Out This Coupon and Envelope
COX-2 protein and gene expression in esophageal and tongue tissue
in normal rats, zinc-deficient rats, and zinc-deficient rats that had
received zinc. They found COX-2 expression was increased 10-fold to
15-fold in zinc-deficient rats. Cellular proliferation was similarly
increased. 
After zinc was given to the deficient rats, COX-2 expression was
markedly reduced and the precancerous cellular proliferation was
reversed. 
The rats lacking dietary zinc were also treated with COX-2 inhibitors,
celecoxib (Celebrex) and indomethacin. They found that the rats
treated with the COX-2 inhibitors had a reduction in both COX-2
and cellular proliferation in the esophagus. 
“Zinc treatment restores many systems affected by the lack of zinc,”
Dr. Fong notes. “Zinc deficiency upregulates COX-2. Zinc replen-
ishment restores it to near normal levels.” In the future, she and her
coworkers would like to determine whether zinc in combination with
low amounts of celecoxib can prevent upper aerodigestive tract
cancers, including esophageal and oral cancers. TJU
These findings suggest that zinc supplements may prevent the
development of esophageal or oral cancers, particularly in developing
countries where zinc deficiency is a problem. Zinc in the diet comes
mostly from red meat and seafood. While 10 percent of Americans
have a zinc-deficient diet, as many as 2 billion individuals in
developing countries are zinc-deficient. Epidemiological evidence
shows that the incidence of esophageal and oral cancers has been
rising in recent years. As many as 13,000 Americans die from
esophageal cancer each year. 
Dr. Fong has been studying zinc deficiency and its connection to
esophageal cancer for some 20 years, and has developed animal
models of zinc deficiency and cancer susceptibility. Zinc deficiency,
she says, increases cell proliferation in the esophagus and in the
tongue, making both areas susceptible to carcinogens and increasing
the risk of cancer development. In 2002, Dr. Fong reported that rats
given a carcinogen while on a zinc-deficient diet developed
esophageal cancer. Giving zinc prevented the cancer. 
Dr. Fong wanted to know if zinc could regulate COX-2 expression in
esophageal and tongue cancers. She and her coworkers compared
Zinc and cancer, continued from page 11
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Pride, according to Webster’s Dictionary, is “delight or satisfaction
in one’s achievements.” This feeling comes naturally to many
Jefferson Medical College alumni, when the magnitude of
Jefferson’s achievements in the care of patients, in the
advancement of medical science, and in the education of medical
and postgraduate students is considered. These achievements are
particularly praiseworthy when one considers that Jefferson has
always been a stand-alone, private medical school and never part
of a full service university or a state supported school. It never had
a university’s associated programs, like athletics, that encourage a
sense of pride. Instead, Jefferson’s sense of itself rests squarely on
the work of its faculty and its alumni. The past and present of
Jefferson Medical College are the foundation for a sense of pride
that should be embraced by all of us.
When Dr. George McClellan, who had founded Jefferson Medical
College the preceding year, insisted in 1825 that Jefferson medical
students be involved in the supervised care of patients in the
school’s attached Infirmary Department, he set off a medical
education revolution, the consequences of which he could not
have imagined. American educators of those days saw neither need
nor purpose for medical students to be involved in the clinical
care of patients, believing that the lectures given by medical
school professors, and repeated verbatim for 2 consecutive years,
were sufficient education. McClellan was ridiculed for his
outlandish concept. Some 180 years later we know that
McClellan’s historic medical student teaching initiative was a
landmark step that evolved over time into the now nationally
emulated clerkship programs for the clinical education of medical
students in every American medical school, and it all began at
Jefferson Medical College in 1825. In addition to this historic
teaching initiative, graduates of Jefferson Medical College were
instrumental in founding 10 other medical schools in the United
States.
Jefferson’s history is replete with medical and surgical greats.
Samuel D. Gross ’1828, the first alumnus to be appointed to a
Jefferson professorship, is recognized as the outstanding American
surgeon of the 19th century. His book Systems of Surgery, first
published in 1859, went through 6 editions and was translated
into several European languages and Japanese. He is immortalized
in the Thomas Eakins portrait The Gross Clinic, painted in 1875. J.
Marion Sims ’1829 is remembered today as the father of modern
American gynecology. Jonathan Letterman ’1849 was a Union
Army surgeon during the Civil War, ultimately becoming Medical
Director of the Army of the Potomac. He developed the first
practical plan for the evacuation of wounded soldiers from the
battlefield, a plan that led directly to the establishment of the
Army Ambulance Corps. Letterman Army Medical Center in San
Francisco is named in his honor. S. Weir Mitchell ’1850 was such
a brilliant neurological researcher and writer that he is often
referred to as the father of American neurology. Carlos Finlay
’1856 studied the epidemiology of yellow fever in his native Cuba
over several decades and was successful in identifying the
mosquito as the carrier of this dreaded disease.
But these are only the beginning. William W. Keen Jr. ’1862 was
Chairman of Surgery at Jefferson in the period 1889 to 1907. In
1876 he was the first Philadelphia surgeon to adopt Lister’s
principles of antisepsis and, in 1887, he became the first American
surgeon to successfully excise a large meningioma of the brain (the
patient lived without recurrence for more than 30 years). In July
1893, Dr. Keen assisted in the operation on President Grover
Cleveland to remove a verrucous carcinoma from the roof of the
president’s mouth. (In all, 19 of the 43 U.S. presidents have been
treated by Jefferson alumni or faculty members before, during, or
after their terms of office.) Keen’s Textbook of Surgery became the
preeminent textbook for surgeons in this country during the period
1906-1921.  
Jefferson was given special recognition in the 1910 Flexner Report
on medical education in the United States and Canada. In addition
to lauding the value of clinical clerkships for the education of
medical students in American medical schools, Flexner pointed out
the excellence of Jefferson’s library. 
John H. Gibbon Jr. ’27 is revered as the father of open heart surgery
worldwide. On May 6, 1953, at Jefferson, he successfully repaired
an interatrial septal defect in the heart of an 18-year-old female
patient while her heart and lung functions were controlled by a
heart and lung machine of Dr. Gibbon’s own design. This brilliant
surgical achievement, the first of its kind anywhere, initiated the
era of open heart surgery for the repair of acquired and congenital
heart defects, as well as for heart transplants. 
A Department of Radiation Therapy and Nuclear Medicine was
established at Jefferson in 1969 under the direction of Dr. Simon
Kramer. The first national randomized study of treating advanced
head and neck tumors by radiation and adjunct chemotherapy had
been initiated by this team of Jefferson radiotherapists the
preceding year. The Radiation Therapy Oncology Group, a
nationwide collaborative group of university departments, was
created by Dr. Kramer in 1969, with its base at Jefferson. In 1972
the National Cancer Institute funded a 10 year study by Dr. Kramer
and his colleagues to determine the patterns of care in cancer
management by radiotherapy. In a first for medicine anywhere, this
study established national benchmarks and a method of quality
assessment for radiation therapy throughout the United States. 
Allen J. Erslev MD, a native of Denmark, joined the Cardeza
Foundation for Hematological Research at Jefferson in 1959 and
directed it from 1963 to 1985. He was the first to demonstrate the
existence of a renal hormone that stimulated red blood cell
production. His later work identified this hormone as erythro-
poietin. Dr. Erslev gave this important information to medical
science freely and now erythropoietin is used to treat the many
patients who, for a variety of reasons, need a boost in red blood cell
production.  
Jefferson Medical College began admitting female medical students
in 1961 and now they represent about one half of each entering
Jefferson Pride
A N N A L S  O F  T H E  M E D I C A L  C O L L E G E
class. Nancy S. Czarnecki ’65, a Philadelphia family physician, was
elected President of Jefferson’s Alumni Association in 1989, and
now serves on the University Board of Trustees as one of the 3
elected Alumni Trustees. Monica Morrow ’76 was recently
recruited to Fox Chase Cancer Center in Philadelphia as the Chair
of Surgical Oncology. Prior to this appointment, she was a
Professor of Surgery at Northwestern University Medical School in
Chicago and Director of its impressive clinical breast program. She
is regarded as one of the country’s leading breast cancer
researchers. 
Since 1964 Jefferson Medical College has been awarding its most
cherished award, the Alumni Achievement Award, to those whose
academic accomplishments have made all of us proud to be fellow
graduates. Since 2000 additional graduates have had their achieve-
ments profiled in the Alumni Spotlight feature which appears in
each issue of the Bulletin. Their achievements should surely be a
cause for pride. 
To date, 2 female graduates have been honored with the Alumni
Achievement Award. Margaret A. Bowman ’76, now Professor and
Chair of the Department of Family Medicine at the University of
Pennsylvania, was the Alumni Achievement Award recipient in
1995, and the very next year Barbara Atkinson ’74, a cytopathol-
ogist, was the honoree. Dr. Atkinson is Executive Dean and Vice
Chancellor for Clinical Affairs at the University of Kansas School of
Medicine, one of only 9 women in the country to serve as a
medical school dean. Dr. Atkinson credits Jefferson with fostering
her interest in academic medicine. 
F a c u l t y
All department chairs at Jefferson now are members of the full time
faculty. Each clinical department has a mix of full time and
volunteer faculty, ensuring that the students are exposed to all
types of medical practice arrangements. For the first 120 years of
Jefferson’s existence, the faculty did little original research because
they were advised by each succeeding dean that their responsibility
at Jefferson was to teach medical students. This attitude gradually
softened between 1940 and 1980, reflecting the nationwide
mushrooming of biomedical research during this period, fueled by
steadily increasing grants disbursed by private and public sources
led by the National Institutes of Health. 
During the 1980s Dean Joseph S. Gonnella MD became convinced
that to flourish in an increasingly competitive health care and
education environment, Jefferson had to add a larger and better
organized research component to its existing educational and
patient care programs, becoming a better balanced medical school. 
Dean Gonnella believed that Jefferson needed, in addition to
cancer clinical programs, basic science researchers on campus who
studied the causes of cancer and other life threatening disorders,
and who could initiate translational research efforts to convert
basic science discoveries into improved patient care. The
University Board of Trustees supported this initiative to increase
Jefferson’s faculty and space. It was an initiative that paid
enormous dividends. Well over half of Jefferson’s faculty members
are currently engaged in sponsored research, a startling
turnaround from the 1940-1970 period. By June 2004, Jefferson’s
annual research income from private and government sources
exceeded $123 million and Jefferson ranked 45th among the 123
medical schools in this country that received grant funds.
Jefferson, now, can truly be called an academic medical center. 
The vitality of a university like Jefferson depends on its ability to
foster and sustain a stimulating research and learning
environment. Access to a world class medical library, excellent
laboratory and clinical facilities, and an exceptional faculty have
infused the Jefferson campus of today with new ideas, energy, and
creativity in diverse areas of medical education, clinical care, and
basic, translational, and clinical research. All Jeffersonians should
take enormous pride in what our medical college has
accomplished since its founding in 1824. And we should take
pride in what is promised to occur at Jefferson in the years to
come. Like any work in progress, however, a medical university
like Jefferson must have regular and sustained financial support
from all who have benefited from being Jeffersonians. 
According to a May 2004 account in The New York Times,
Germany’s Heidelberg University, founded in 1386 and renowned
worldwide for its academic excellence, has been slipping recently.
The reason given is decreasing financial support. As one of its
celebrated faculty members puts it, “To be in the top, you have to
be continually supported.” The same argument can be made for
Jefferson Medical College. Our school has gained an enviable
reputation over the years based on the good doctors it produces,
the educational advances it champions, and the medical research
it shares with the community and with the world. These proud
activities must not be allowed to diminish because of lessened
financial support from the alumni, the principal beneficiaries of
Jefferson’s strong reputation. 
What Jefferson can become with our continued and increasing
financial support is the basis for our Jefferson pride. All of us who
have gained from the school’s legacy and future promise must
agree that what has happened recently to Germany’s Heidelberg
University must never be allowed to happen to Jefferson Medical
College. 
John J. Gartland S’44
Phillip J. Marone ’57
Malcolm Clendenin, Editor, Alumni Bulletin
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'42
Edgar Gibson and his wife,
Helen, are living in Boothbay,
ME. They recently built a new
house. Ed supervised its design
and construction and is still
adding features. He plays tennis
or works out at the YMCA daily.
"Would love to hear from
classmates." 
'46
G. Robert Senita of Wexford, PA
was inducted into the Franklin
and Marshall College Athletic
Hall of Fame for cross country
running in October 2004.
'48
George Risi has moved to
Melbourne, FL after 18 years of
living in Montana. "Getting too
old for the weather and the
rugged lifestyle."
'52
Kurt Lauer of Yonkers, NY is still
practicing cardiology and is the
medical administrator of a small
group practice. He would enjoy
seeing classmates.
'53
Joseph Armao of Springfield, PA
is currently serving as Medical
Director of Fair Acres Geriatric
Center in Lima, PA.
Henry Kane of Wilmington, DE is
working part time at the Alfred I.
duPont Hospital for Children.
'54
John Purnell of State College, PA
is happily retired but finds
himself returning to classes at
Penn State. He is taking 3
courses a semester and enjoying
every class. His main interest is
astronomy and early religious
history. Tennis, golf, and
vegetable gardening fill in the
extra time.
A. G. Scottolini of Spokane, WA
is working part time as a medical
consultant for the State of
Washington, Department of
Social and Health Services,
Division of Disability
Determination Services. In
addition, he fills locum tenens
positions in pathology a couple
of times annually. "Despite
professional demands, manage to
travel and enjoy my so called
retirement." 
'56
Wallace Miller of Philadelphia
has been named to the 2003-04
edition of Best Doctors in
America. His book Field Guide to
the Chest X-ray has been
translated into Chinese. 
'57
Jerry Labriola of Naugatuck, CT
is still writing murder mysteries
as well as books in collaboration
with forensic scientist Dr. Henry
Lee. The Maltese Murders and The
Budapest Connection will be
released this summer. A new
book is under way which will
include the Scott Peterson case.
'58
Richard Eshbach of Loutraki,
Greece had a nice visit with
classmate Jay Hughes and his
wife, Lynn, in October. "Wish we
could have more visitors here in
Greece, the land of the Olympics
in 2004!"
Bert Hurowitz of Scottsdale, AZ
is Chief of Rheumatology at the
Maricopa Medical Center in
Phoenix. He teaches in the
medical residency program.
Robert Somers of Elkins Park, PA
stepped down as Chair of the
Department of Surgery at Albert
Einstein Medical Center in
January after more than 20 years
as Chair. He will continue to
practice surgery, limited to breast
cancer, and teach the Jeff
students who rotate through
Einstein in their 3rd and 4th
years.
'60
Health Press in Oxford, England
has just published David Green's
latest book, Bleeding Disorders.
He is into his 36th year at
Northwestern University,
teaching students, doing
research, and caring for patients.
He resides in Chicago.
'61
William Anderson of Somerville,
NJ is now fully retired and
enjoying not having night calls,
beepers, and insurance forms. 
Maurice Lewis of New
Cumberland, PA is teaching
history taking and physical
diagnosis to first year medical
students from Penn State Medical
College in Hershey. 
'62
Robert Glazer of Wynnewood,
PA left private practice and has
been doing orthopaedics at the
Wilmington VA Medical Center.
Mark Pliskin of Canadensis, PA
picked up a new sailboat in
California in April 2004 and
sailed it from Newport Beach, CA
to the Chesapeake Bay via the
Panama Canal. He arrived in
Havre de Grace, MD on July 3,
2004 after a "great" trip of 6,400
nautical miles. 
'63
Herbert Rader of Floral Park, NY
is Senior Vice President for
Medical Affairs, New York
Community Hospital in
Brooklyn, NY, and Medical
Consultant for the Salvation
Army USA, Eastern Territory. 
'64
James Barton of Chambersburg,
PA writes, "Advice needed! At
66, I am close to retirement. How
does one leave a practice where
there are thousands of patients
who have become friends? No
matter, for with the continued
thinning of my cortex, and the
loss of a synapse here and there,
I'll just start showing up at the
wrong office." 
Anthony Harrison of Pittsburgh is
still working and "still loving it."
He operates 3 days a week. 
Charles Thompson of Lake
Arrowhead, CA is doing occupa-
tional medicine 50 hours per
week with no plans to retire.
John Whitecar of Columbus, MS
is still practicing hem/onc.
Daughter Linnane Batzel '99 is
practicing emergency medicine
in Altoona, PA and youngest
daughter Colleen is a 3rd year
medical student at Jeff.
'65
Nancy Czarnecki "thanks the
alumni for the awesome
experience of serving on the TJU
Board of Trustees." She
continues to work at Aetna,
Incorporated. Oldest son Joseph
'95 completed his orthopaedic
residency at Harvard Medical
School and is now in his sports
medicine fellowship at
Massachusetts General Hospital.
"Let's get together with all our
'65 classmates and make this
40th reunion a bash!"
William Wood of Mankato, MN
continues in a part time anesthe-
siology practice primarily at
surgicenters and enjoys teaching
students. He also is traveling and
"trying to believe that golf is a
learnable game."
Dick Dunkelberger '60
catches up with Neil
Feins '60 at Neil's
house on Narragansett
Bay in Rhode Island.
Neil is still on staff in
pediatric surgery at
Children's Hospital
Boston.
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Alumni Spotlight:
Robert Tesh ’61
Jefferson Medical College
turns its Alumni Spotlight on
Robert B. Tesh ’61 whose
professional accomplishments
have brought honor and
prestige to our medical
college. Dr. Tesh completed a
rotating internship in
California at San Francisco
General Hospital and then,
motivated by a curiosity about
tropical infectious diseases,
spent a year as resident in
pediatrics at Gorgas Hospital
in the Panama Canal Zone. He
then enlisted in the commis-
sioned corps of the U.S. Public
Health Service and spent 2 years
in northeast Brazil, an
experience that solidified his
interest in tropical infectious
diseases. He earned an M.S.
degree in epidemiology at
Tulane University between 1965
and 1969, a time during which
he recognized that his real
professional interest lay in
research rather than in clinical
medicine. He then joined the
staff of the National Institute of
Allergy and Infectious Diseases
of the National Institutes of
Health. He spent 5 years in an
NIAID field laboratory in
Panama, followed by 7 years in
an NIAID field laboratory in
Honolulu.
He left the NIH in 1980 when he
was recruited to the Yale
University School of Medicine as
an Associate Professor of
Epidemiology, with a position in
the Yale Arbovirus Research
Unit. He remained at Yale for 15
years, rising to Professor of
Epidemiology in 1989. In 1995
he became the George Dock
Distinguished Professor of
Pathology in the Department of
Pathology and the Center for
Tropical Diseases at the
University of Texas Medical
Branch, Galveston, TX. Dr. Tesh
notes that over the past 10 years
it has become one of the premier
centers for research and
training in emerging and
tropical infectious diseases. 
Tesh freely admits that most of
his medical career has been
spent in field and bench
research on the epidemiology
and pathogenesis of a variety of
vector-borne viral and parasitic
diseases. His current research is
aimed at West Nile
encephalitis, yellow fever, and
arenaviral hemorrhagic fever.
His career has taken him to
work in many fascinating places
to work, such as South
America, Asia, Africa, and the
Middle East.
Tesh has been the principal
investigator on 15 funded
research projects totaling over
$20 million in grant funds. He
is the author or coauthor of 211
peer reviewed journal articles
and 23 book chapters in his
field of interest. At present, he
serves on 2 editorial boards and
functions as a manuscript
reviewer for 15 other journals
in this country and abroad. He
holds memberships in 8 profes-
sional organizations
internationally, including the
American Association for the
Advancement of Science, the
American Society of Tropical
Medicine and Hygiene, the
American Society for
Microbiology, and the Royal
Society of Tropical Medicine
and Hygiene.
Strong influences on him at
Jefferson were Dr. Ken
Goodner’s lectures in microbi-
ology and Dr. John Hodges’s
course in laboratory medicine.
He notes that Goodner had
worked at the Rockefeller
Foundation and had spent time
in Africa before coming to
Jefferson. As a consequence of
this experience, he brought
firsthand accounts of diseases to
his lectures. “Those 2 courses
made a lasting impression on
me,” says Dr. Tesh. 
One of his most vivid memories
of Jefferson was the large
painting of Carlos Finlay ’1855,
the Cuban physician educated at
Jefferson who identified the
mosquito as the vector of yellow
fever. The portrait hung in the
stairwell of one of the lecture
buildings. Dr. Tesh tells the
Alumni Bulletin he had the
opportunity to visit Dr. Finlay’s
grave in an old section of
Havana in 1984, a visit he
cherished particularly because
he believes he and Carlos Finlay
shared similar origins and
interests. We congratulate Dr.
Robert B. Tesh ’61 on a 
distinguished professional career
and thank him for bringing
honor and distinction to
Jefferson Medical College.
'66
Ken Heaps is currently
commuting weekly from York,
PA to Chicago to work as VPMA
for Central DuPage Hospital in
Winfield, IL. He decided he
wasn't ready for retirement after
all. He is enjoying the people and
the work and thus far doesn't
mind the travel. 
W. Scott Williams of Millville, NJ
has been named the 2004 South
Jersey Healthcare Physician of
the Year. His service on the
Medical Executive Committee
spans 4 decades; he was the first
President of the joint
Bridgetown-Millville-Elmer
Medical Staff and also involved in
the development of the health
system's JointCare program,
which brought an innovative
joint replacement philosophy to
South Jersey Healthcare.
'67
Anne Thompson of Great Falls,
VA is a Clinical Professor of
Medicine at George Washington
University. She also has a busy
nephrology practice. Husband
Bill is in a private psychiatry
practice.
'68
Joel Barish of Cherry Hill, NJ has
finally retired. His last working
year was in Tokyo, as a visiting
Professor in Medicine. He has
returned to northern Nevada to
enjoy the beautiful scenery. "In
almost 40 years of medicine, I
have never met anyone who
received a better medical
education than all of us."
John Frost of Anchorage, AK has
limited his orthopaedic practice
to arthroscopic knee surgery for
the past 18 years. He has been
Chief of the Medical Staff at
Alaska Regional Hospital and is
currently serving on the
hospital's Board of Trustees.
Joseph Glaser has moved to
Salem, OR after 26 years in
Coronado, CA in a private
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Leon L. Berns '30 died December
26, 2004. He had been in the
general practice of medicine in
Philadelphia for 70 years and
was on staff at Einstein Medical
Center during his entire medical
career. He also served as Clinical
Professor of Anatomy at
Jefferson from 1931 until 1993,
and is fondly remembered by
many on campus. He is survived
by his wife, Mildred, a son, and a
daughter.
Lawson E. Miller Jr. '34 died
November 5, 2004. He practiced
radiology in New York City and
held a part time faculty
appointment at Columbia-
Presbyterian Medical Center. He
is survived by his wife, Elsie.
F. Johnson Putney '34 died
December 18, 2004. He was
Clinical Professor of
Laryngology and
Bronchoesophagology at
Jefferson until 1967 when he
became Professor of
Otolaryngology/Head and Neck
Surgery at the Medical
University of South Carolina. He
was the author or coauthor of
107 published articles and 10
book chapters, and served on 4
editorial boards. He was
President of the American
Broncho-Esophagological
Society in 1961, and President of
the American Laryngological
Society in 1971. He is survived
by his wife, Virginia, 3 sons, and
a daughter.
John L. Gompertz '36 died
November 14, 2004. A member
of Alpha Omega Alpha Honor
Medical Society, he practiced
internal medicine in Oakland,
CA. He was President of both
the California and Alameda
County Tuberculosis and Health
Associations. He was a past
President of the California
Thoracic Society, as well as the
American Lung Association. He
is survived by his wife, Margaret,
2 daughters, and a son.
H. Richard Ishler '36 died
September 17, 2004. He
practiced family medicine in
State College, PA until 1997. He
held a staff appointment at
Centre Community Hospital in
State College. He is survived by
his wife, Mary Jane, a son, and a
daughter.
R. Howard Lackay '38 died
October 10, 2004. A Colonel in
the U.S. Air Force Medical
Corps, he served as deputy
Commander of the Aerospace
School of Medicine, Brooks Air
Force Base, and of the Air
Training Command Medical
Wing, Randolph Air Force Base.
He was working in the station
hospital at Schofield Barracks,
Oahu, HI on December 7, 1941
when Japanese planes attacked
Pearl Harbor. He is survived by
his wife, Laura Jane, and 2
daughters.
J. Woodrow Savacool '38 died
January 13, 2005. He was in the
private practice of internal
medicine and chest diseases for
45 years and, since 1942, had
been a Clinical Associate
Professor of Medicine at
Jefferson. He served as
President of the Laennec
Society of Philadelphia, the
Pennsylvania Thoracic Society,
and the Pennsylvania Chapter
of the American College of
Chest Physicians. Dr. Savacool
collaborated with Frederick B.
Wagner Jr. '41 in writing and
publishing a 3-volume history
of Jefferson (1989-1996). He
was presented with an
Honorary Doctor of Letters
degree from Jefferson Medical
College in 2004. The J.
Woodrow Savacool Prize in
Medical Ethics was established
at Jefferson upon his retirement.
He is survived by a son and a
daughter.
Arthur F. Hoffman '41 died
October 26, 2004. He practiced
anesthesiology at St. Joseph's,
Lutheran, and Parkview
Hospitals, Fort Wayne, IN. In
1983 he was awarded the
Indiana Physician of the Year
Award for his community
service. He is survived by his
wife, Mary, 6 sons, and 3
daughters.
Phil L. Barringer '42 died
October 25, 2004. He had
practiced general surgery in
Monroe, NC. He was on staff at
Union Memorial Hospital,
Monroe, where he served as
Chief of Surgery and as Chief of
Staff. He is survived by his wife,
Vivian, 3 daughters, and 2 sons.
Howard M. Oliver J'44 died
September 12, 2004. He served
as Chief Pathologist at the
Cheshire Medical Center,
Keene, NH. He also served as
President of the Cheshire
County Medical Society in 1960
and again in 1985. He is
survived by his wife, Myra, 2
sons, and a daughter.
Charles E. Hannan '46 died
October 20, 2004. He practiced
general and colorectal surgery at
the Virginia Hospital Center in
Arlington, VA. He had served as
a Clinical Instructor in Surgery
at Georgetown University
Medical School, and was a past
President of the Arlington
County Medical Society. He is
survived by 4 sons and 3
daughters.
Frederick Urbach '46 died July
8, 2004. He was a noted
dermatology researcher. He
served as the Chief Cancer
Research Dermatologist,
Roswell Park Memorial
Institute, Buffalo, NY, Medical
Director, The Skin and Cancer
Hospital of Philadelphia, and
Professor and Chairman,
Department of Dermatology,
Temple University School of
Medicine. He published 85
scientific articles and 2 books in
his field of expertise. He is
survived by 3 sons.
Robert B. Funch '47 died August
5, 2004. He was Chief of
Radiology, Germantown
Dispensary and Hospital, 1968-
77, and Clinical Professor of
Radiology, Temple University
School of Medicine, 1963-77.
From 1977 until 1987 he was
Director of Radiology, Memorial
Hospital, Norway, ME. He is
survived by his wife, Beatrice,
and 2 daughters. His father was
Jefferson '20 and a brother was
Jefferson '47.
Gail G. L. Li '47 died October
17, 2004. He practice obstetrics-
gynecology in Honolulu and
was on staff at the Queen's
Medical Center, Honolulu.
Daughter Gaylyn is Jefferson '78
and daughter Sheryl is Jefferson
'92.
Richard E. Strauss '47 died May
12, 2004. He practiced
dermatology in Bristol, PA. He
is survived by a son and a
daughter. 
Julio J. Amadio '48 died January
4, 2005. He practiced internal
medicine within the Jefferson
Health System, holding staff
appointments at Paoli Memorial
Hospital and Bryn Mawr
Hospital. He is survived by his
wife, Judith, and 2 daughters. 
Joseph G. Matthews '52 died
December 9, 2004. He practiced
orthopaedic surgery in Orlando,
FL where he headed the
Matthews Clinic, and was a past
President of the Florida
Orthopaedic Society. He was on
staff at the Orlando Regional
Medical Center. He is survived
by 2 daughters and a son. 
William J. Walker III '53 died
June 24, 2004. He practiced
obstetrics-gynecology and was
on staff at Chestnut Hill
Hospital in Philadelphia. He
relocated to Irvine, CA in 1977
to work for Kaiser Permanente.
He is survived by 2 daughters
and a son.
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practice. He is now doing
gastroenterology for Northwest
Permanente. 
James Turchik has retired from his
position as Clinical Professor of
Medicine at SUNY Upstate and
Director of Infectious Disease at
Crouse Hospital. After 30 years in
Syracuse, NY, he and wife Evelyn
have moved to Sarasota, FL. He is
now taking piano lessons and
running in the Sarasota Senior
Games. 
'70
Lou Freeman of Fresno, CA
completed the Singlehanded
TransPacific Yacht Race to Hawaii
in 2002 and plans to go again. He
continues his private anesthesi-
ology practice and his medical
directorship at Fresno Surgery
Center. 
Marilyn Kershner of Coronado, CA
is still at Kaiser Permanente in San
Diego. "Despite its flaws, it insures
the sick, not only the healthy."
Charles Schleifer of Penn Valley,
PA chairs the Patient and Family
Council and is Chairman-Elect of
the Delaware Valley Chapter of the
National Kidney Foundation.
'71
Michael Blecker of Milltown, NJ
has moved on to the emergency
department at Lenox Hill Hospital-
Manhattan after 25 years as an
attending at St. Vincent's Hospital-
Manhattan.
Robert Chandlee of Atlanta is in
his 30th year of diagnostic
radiology practice. In this time,
Quantum Radiology Northwest
has grown from 3 to 35 and is the
largest single-specialty private
practice group in the state.
Edwin Ewing ran the 2004
Thanksgiving Day Marathon in
Atlanta, where he lives. He was
one of just 8 male finishers his age
(61) or older. He and Kim Kahng
'79, retired from surgery and
pathology, respectively, performed
Jack G. Watkins '53 died
October 31, 2004. He practiced
pediatrics and was on staff at
Sutter-Amador Hospital in
Jackson, CA. He later developed
the Pediatric Department at
Roseville Community Hospital,
Roseville, CA. He is survived by
his wife, Katherine, 4 sons, and
a daughter.
Stewart E. First '56 died
December 3, 2004. He practiced
at Lankenau Hospital,
Wynnewood, PA where he was
Chief of Gynecology, and also at
Paoli Memorial Hospital, Paoli,
PA. He was a Clinical Associate
Professor of Obstetrics-
Gynecology at Jefferson Medical
College. He is survived by his
wife, Sandra, 2 sons, and a
daughter. His brother, Howard,
is Jefferson '55.
Peter Amadio Jr. '58 died
December 7, 2004. A Professor
of Family Medicine at Jefferson,
and a very popular teacher, he
was awarded the Christian R.
and Mary F. Lindback Award
for Distinguished Teaching at
Jefferson's Class Day
ceremonies in June 1989. His
career was highlighted by
service to others, including
numerous Jefferson medical
students. He is survived by his
wife, Vilma, 2 sons, and 2
daughters. Son Peter C. is
Jefferson '73 and daughter
Patricia is Jefferson '89.
Donations are suggested to the
Juvenile Diabetes Foundation,
Bala Cynwyd, PA, or the Mayo
Foundation, Brain Research
(Allen Brown MD), Rochester,
MN.
Jackson V. Scott '59 died
September 17, 2004. He was a
general practitioner in Mount
Holly, NC for 42 years. He
enjoyed a busy practice,
delivering more than 1,000
babies in his first 10 years of
practice, and had a patient base
of over 5000 people during his
years in Mount Holly, NC. He is
survived by his wife, Jane, 2
sons, and a daughter.
Samuel M. Eppley '61 died
October 8, 2004. He was in
general practice in Enosburg
Falls, VT. Locally active in his
community, he received the
Robbins Community Service
Award and was chosen Family
Physician of the Year by the
Vermont Academy of Family
Physicians in 1992. He was a
past President of the Franklin
County Medical society. He is
survived by his wife, Linda, a
son, and a daughter.
Paul J. Coverdale '69 died
November 25, 2004. Board
certified in internal medicine, he
was on staff at Doylestown
Hospital, Doylestown, PA. He is
survived by 3 sons and a
daughter. Brother Edward is
Jefferson '67. 
Robert F. Chatfield-Taylor '70
died October 3, 2004. He
practiced psychiatry in
Brookline, MA. He was on staff
at Taunton State Hospital,
Taunton, MA. He is survived by
2 daughters and a son. 
Cheryl R. Zaret '72 died
November 18, 2004. She was on
staff at Northwestern Memorial
Hospital in Chicago where she
served on the hospital's Medical
Executive Committee. She was
an Assistant Professor of
Ophthalmology and Neurology
at Northwestern University
School of Medicine. She is
survived by her parents and her
brother, Bruce Zaret, Jefferson
'74.
David E. Nutter ’76 died
September 20. He practiced
psychiatry in Lancaster, PA and
was a partner in Mid Atlantic
Psychiatric Physicians with
Kurtis D. Jens, Jefferson '76. He
had been on the staff of
Lancaster Regional Medical
Center and held privileges at
Lancaster General Hospital. He
is survived by David and Aaron,
sons of Rita Nutter; Ivory,
daughter of Susannah Nutter;
and his companion, Carol
Emerson. His father was P.
David Nutter, Jefferson '35.
Amy Lu Weaver '85 died
September 26, 2004. She was an
attending family physician,
Department of Emergency
Medicine, Lewistown Hospital,
Lewistown, PA, and also served
as Director of the Tyrone
Hospital Emergency
Department. 
Postgraduate
Rafik Zaky Makary P'73 died
April 15, 2004. He was a
psychiatrist with the Veterans
Administration Hospital,
Philadelphia. 
Faculty
William Fraimow MD,
Honorary Associate Professor of
Medicine, died October 26,
2004. He practiced both
internal medicine and
pulmonary medicine at
Jefferson and was a steady
influence in the Student and
Employee Health Service. He
was a gifted teacher and an
excellent role model for
hundreds of medical students
and residents at Jefferson. He is
survived by his wife, Gloria, 3
sons, and a daughter.
E. Marshall Goldberg MD,
Professor of Medicine,
Psychiatry, and the Creative
Arts, died January 20. An
endocrinologist, he joined
Jefferson's faculty in 1989,
having already established a
2nd career as a writer of
medical mysteries. One of his
novels, The Family Scalpel, was
set at Jefferson. In 1995 he was
chosen Teacher of the Year by
residents in the Department of
Medicine. He also received an
appointment in the Department
of Psychiatry. Survivors include
2 sons and 3 daughters.
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new career. He is now a full time
public health director for the
Western Tidewater Health
District in the southeastern part
of the state, including 2 cities
and 2 rural counties. He also
continues as head of the
statewide Terrorism and Disaster
Behavioral Health Advisory
Council.
John Hocutt continues a full time
family medicine practice in
Wilmington, DE where he works
with Jefferson medical students.
Daughter Beth Lyn is in the Class
of '08 at Jefferson.
Bob Sataloff of Bala Cynwyd, PA
remains active at TJU as
Professor of Otolaryngology and
is celebrating the 35th
anniversary season of the TJU
Choir. He is also Chairman of the
Board of Governors and of the
Otolaryngology Department at
Graduate Hospital. He continues
to write prolifically, having
produced more than 500 medical
publications; his 35th and 36th
textbooks will be published this
year. He is married to Dahlia M.
Sataloff, Chair of the Department
of Surgery at Graduate Hospital,
and their twins, Ben and John,
turned 13 in January. 
Brad Wong of Honolulu has been
traveling to the Philippines in
1988-2000 and more recently to
Vietnam in 2002-2004 to operate
and teach general surgery. He
welcomes anyone interested in
traveling with his group to
provide medical or surgical
services to the poor in these
countries.
'76
David Willis maintains a private
practice of behavioral-develop-
mental pediatrics at Legacy
Emanuel Children's Hospital in
Portland. His current focus is as
Director of the Northwest Early
Childhood Institute, dedicated
to the psychosocial and
developmental health of
infants and young
children. He is Vice President of
the Oregon Pediatric Society.
'78
Robert Boran of Pottsville, PA was
elected to the Board of Directors of
the Eastern Orthopaedic
Association in October 2004.
Kenneth Neifeld of Bradenton, FL
remains busy with an internal
medicine practice in St. Petersburg,
in addition to teaching University
of South Florida medical students. 
'79
Robert Bashore of Indian Harbor
Beach, FL was elected President of
the Medical Staff at Cape Canaveral
Hospital in Cocoa Beach. He's
relieved to report that his family,
home, and office survived all 3
hurricanes without a scratch.
Carol Narkevic has been a medical
missionary with the Catholic
Church since 1990, first serving in
the bush and desert of Kenya for 3
years, then in Jamaica and the
West Indies for the past 11 years.
Presently, she is the Medical
Coordinator of the Medical
Ministries in the Diocese of
Mandeville, Jamaica.
Vikki Stefans of Little Rock is still
practicing pediatric PM & R in
Arkansas with a "wonderful"
colleague. They are expanding
their efforts to the adults in the
developmental centers, and have
been around long enough to watch
many of their patients grow up and
graduate. 
Sandra Willingmyre of Cherry Hill,
NJ continues as Clinical Director of
the Internal Medicine Division of
Camcare Community Health
Center in Camden. The office
received accreditation as an
American Diabetes Association
Center of Excellence for diabetes
care in June 2004. 
'80
Charles Dunton of Broomall, PA
has been named Director of
Gynecologic Oncology at
a 4-hand (2-piano) concerto at a
Sonata Piano Camp recital in
Bennington, VT in September
2004 after meeting at Sonata the
previous year. 
George Wineburgh has relocated
to Lake Worth, FL to practice
rheumatology part time and sail
most of the time.
Nancy Wong of Palo Alto, CA,
after years of a private
dermatology practice and raising
a family, is now allowing herself
to explore other interests. She is
doing landscape watercolor
paintings and photography. You
can visit her website:
watercolourartworks.com.
'72
Philip DiGiacomo of Wayne, PA
is proud to share that his son,
Philip DiGiacomo III, is in the
Class of '08 at Jefferson.
Jim Redka of Williamsport, PA
has been an active family
physician for 25 years. He enjoys
teaching residents and students.
'73
Anton Kemps is still living
in Haddonfield, NJ with
wife Tina. He
practices primary
care internal
medicine
full time
and
is a Clinical Professor at UMDNJ-
Robert Wood Johnson School of
Medicine.
Michael Wrigley of Jeffersonville,
PA is currently the Medical
Director at Academy Industrial
and Occupational Health Services
in Northeast Philadelphia. 
'74
Elizabeth Kuhlmann Blackwell of
Highland, UT is a co-author and
consulting editor of a new book,
Choose the Right Tests: Endocrine
Disorders.
Albert Blumberg of Baltimore,
MD has been reelected as Vice
Speaker of the American College
of Radiology. He was elected to
the Board of the American
Society for Therapeutic
Radiology and Oncology as Vice
Chairman of the Government
Relations Council. 
John Lubicky of River Forest, IL
has left Shriners Hospital after
almost 17 years to be full time at
Rush University Medical Center
and Rush Medical College in
Chicago. His new titles include
the Ronald L. De Wald Professor
of Spinal Deformity, as well as
Professor of Pediatrics.
'75
William Biermann of Blue Bell,
Pa has fully recovered from a
heart transplant in 2001 and is
currently President of the
Medical Staff at Montgomery
Hospital in Norristown. He is
also in the American College
of Physician Executives
MBA program.
Mark Dembert
of Norfolk,
VA has
started
a
M
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Editor of the national newsletter
ASF Source. He is a senior partner
at the Georgia Institute for
Plastic Surgery in Savannah, GA
where he also resides with his
family.
Elizabeth Squiers is still living in
beautiful Half Moon Bay, CA.
She is working with Thios
Pharmaceuticals as Vice
President of Development.
'84
Jonathan Daitch continues to
practice full time pain
management in Fort Myers, FL
where he lives with his wife and
3 daughters. 
J. Christopher Daniel has moved
from Jakarta, Indonesia to
Mystic, CT. He is now the
Commanding Officer of the
Naval Submarine Medical
Research Laboratory in Groton. 
Terry Lynn Edwards is currently
the Chair of the Evaluation and
Competence Committee for the
University of Pittsburgh's
Anesthesiology Residency
Program. 
Evan Liu of Media, PA has
embarked on a career change,
suspending his medical practice
while studying law full time at
Widener University School of
Law. 
Guy Stofman of Pittsburgh is the
2004-2005 President of the
Pennsylvania Plastic Surgery
Society.
'85
Linda Frantz of Scranton, PA is
President of the Lakawanna
County Medical Society.
'86
W. Bradford Carter is an
Associate Professor of Surgical
Oncology at H. Lee Moffitt
Cancer Center and Research
Institute in Tampa. He has an
extramurally supported basic
science research lab and leads the
Endocrine Tumor Team. He lives
in Lutz, FL with wife, Janie, and
3 children. 
Kenneth Margulies of Villanova,
PA has joined the faculty of the
University of Pennsylvania and
assumed the role of Director of
Heart Failure and Transplant
Research within the university's
new Cardiovascular Research
Institute.
'88
Ed Kim and wife Lori of Bernards
Township, NJ welcomed the
birth of twins Eliza Grace and
Anneliese Rose on September 28,
2004. Big sister Olivia, a
seasoned 6 year old, is a devoted
3rd parent. Professionally, Ed
received his MBA from the
University of Massachusetts and
has been appointed Vice Chair
for Clinical Programs in the
Department of Psychiatry at
UMDNJ-Robert Wood Johnson
Medical School, and Vice
President for Acute and
Geropsychiatric Services. The
only other thing he wants "is
some sleep." 
Jeffrey Lederman is an infectious
disease physician at Sound Shore
Medical Center in New Rochelle,
NY. He specializes in HIV care,
tuberculosis and travel medicine.
David Williams is currently
serving as the Commander of the
Medical Operations Squadron at
Fairchild Air Force Base in the
state of Washington.
'89
Daria Yanez is in a group ob/gyn
practice at Riddle Memorial
Hospital in Media.  
'90
Michael Dannenberg has been
elected President of the Long
Island Dermatological Society.
Vik Kashyap and wife are still at
the Cleveland Clinic Foundation.
They reside with their 3 children
in Moreland Hills, OH.
Lankenau Hospital.
Thomas Griffin of Flourtown, PA
has recently served as President
of the Philadelphia Dermatology
Society, President of the
Pennsylvania Academy of
Dermatology, and Chairman of
the Section on Dermatology of
the College of Physicians of
Philadelphia. 
Arthur Shedden and family have
been "blessed" by their relocation
to the Warren, NJ area. As Vice
President of Global Medical
Affairs at Schering-Plough, he
directs Phase 4 clinical research
in allergy and respiratory
diseases.
'82
Neal Schorr coauthored The
Pennsylvania Turnpike which was
recently released by Arcadia
Publishing. Neal's interest in the
turnpike was prompted by his
travels on the highway between
Philadelphia and his hometown
of Pittsburgh while he attended
Jefferson Medical College. He is
currently practicing family
medicine and living in Wexford,
PA with his wife Kimberly, son
Steven, and daughter Caroline.
'83
Aaron Bleznak and family have
moved to the Allentown, PA area
where he will serve as Vice Chair
of Surgery at Lehigh Valley
Hospital and be a member of the
Division of Surgical Oncology.
David Kramer of Jacksonville, FL
has been promoted to full
Professor of Medicine at the
Mayo Clinic Jacksonville. He is
working as Director of
Transplant Critical Care,
providing critical care services
for liver, kidney, and pancreas
transplant recipients.
Richard Greco has been elected to
the Board of Trustees of the
American Association for
Accreditation of Ambulatory
Service Facilities and serves as
" L o s t  o n  4
C o n t i n e n t s "
Charles Bryner ’81, after 27
years, 3 months, and 26 days of
military service, has separated
from the United States Navy.
He was commissioned straight
out of college in 1977 under a
scholarship program and
officially retired October 1,
2004. He had no intention of
making a career of the navy
when he first raised his hand,
but along the way he had "not
just a career, but a life: I have
gone to 22 countries and a few
colonies, have had 12 addresses
from sunny southern California
to New England, overseas, and
Jacksonville. I have wet my feet
in 5 of the 7 seas and have
been lost on 4 continents. 
I have eaten foods that I will
never exactly know the contents
of, and may not want to. I have
been launched off an aircraft
carrier, taught to arm and
disarm live mines, and lived in
a tent for months at a time in
the cold winters of Korea and
the heat of Guantanamo Bay. 
I have fashioned furniture from
empty MRE boxes and learned
how to make do with what they
had at hand rather than worry
about what they did not have. 
I have eaten C-rats that were
canned before I was born and
flown in more types of aircraft
that I can recall. I have been a
part of the NASA Shuttle
program and a Scout leader. 
I have delivered hundreds of
babies and sat with patients as
they died before my eyes. I have
gone on humanitarian missions
and fast-roped out of
helicopters. But mostly, I have
had the honor of taking care of
thousands and thousands of the
men and women who serve this
country every day. It has been a
wonderful life." Dr. Bryner
received the Legion of Merit for
his accomplishments and will
be taking up the private
practice of family medicine in
Orange Park, FL.
'92
Steve Chasen, an Associate
Professor of Obstetrics and
Gynecology at Cornell University
Medical College, has been named
ob/gyn residency director at the
New York Hospital. He also
serves as the fellowship director
of maternal-fetal medicine. Steve,
his wife Wendy, and their 3-year-
old son Isaac couldn't be happier
living in Manhattan.
Orlando Cicilioni of Apopka, FL
opened his new practice,
Orlando Cosmetic Surgery, in
August 2004. 
Alicia Daniels and husband
Christopher Wagner of Medford,
NJ are pleased to announce the
birth of their 2nd son, Colby
Richard. Big brother Luke just
turned 4 years old.
Randy Miller and his wife Jiyon
had a baby girl, Alexa, on August
9, 2004. They reside on Brickell
Avenue in Miami.
Jennifer Naticchia of
Haddonfield, NJ was appointed
Residency Director of the
Department of Family and
Community Medicine at
Christiana Care in Wilmington,
DE in September. She is honored
and looks forward to
interviewing many Jefferson
students when they come for
interviews and teaching Jefferson
students when they come for
rotations. Other Jeffersonians in
her department include Janice
Nevin '87, Heather Bittner-Fagan
FP'03, Dave Bercaw '81, Cathryn
Savoca '99, and "there are more."
'93
Eileen Conti and husband, Vin
Hoye MD, of Chester, NJ are
pleased to announce the birth of
their first child, Ann Patricia
Hoye, born June 30, 2004.
Daniel K. Meyer holds a faculty
position as Assistant Professor of
Medicine at UMDNJ-Robert
Wood Johnson Medical School.
In the past year he was appointed
program director for the
fellowship training program in
infectious diseases at Cooper
University Hospital, Camden. He
also published a chapter in the
international reference text for
infectious diseases: Principles and
Practice of Infectious Diseases, 6th
edition, edited by Mandell,
Bennett, and Dolin. 
Daniel writes, "With my life
partner, Frederick Haas, I
continue to be active in philan-
thropic causes. Current projects
include the support of AIDS
research and training programs
in Africa as well as local arts and
culture institutions."
Michael C. Sokol has accepted a
position with GlaxoSmithKline,
the world's 2nd largest pharma-
ceutical company, as Medical
Director, Medical Affairs /
Commercial Operations, within
the Managed Markets Division.
In this role, Dr. Sokol is respon-
sible for clinical support for
major accounts, oversight of
disease management programs,
and client-specific health
outcomes studies, as well as
health policy activities. He most
recently served as Senior
Director, Medical Policy and
Programs, Department of
Medical Affairs, at Medco Health
Solutions, one the of nation's
leading pharmacy benefit
management companies.
'94
Cary Rose and wife Stefanie of
Minneapolis announce the birth
of their 2nd child, Maxwell
Mason, on September 20, 2004.
Max joins his sister, Josie, who is
one year older. Cary is a
practicing cardiologist and
surgeon, and "proud to be the
only Eagles fan in the entire state
of Minnesota."
Jay Schwartz of Ridgeland, MS
has been appointed Assistant
Professor of Radiology in the
Division of Minimally Invasive
Therapy and Interventional
Oncology at the University of
Mississippi School of Medicine.
'95
Barbara Ioannides resides in
Jacksonville, FL with husband
Ken Rappaport MD, a retina
specialist, and their 3 children.
She has a solo internal medicine
practice.
'96
Kristin DeSimone and husband
Joe ID'99 of Mullica Hill, NJ
welcomed their new child Mark
in March 2004. Big siblings, Joey
and Katie, adore their brother
and are a terrific help. Kristin is
in her 4th year in the Student
Affairs Office at Jefferson and
truly enjoys interacting with so
many JMC students.
John Findley of Winchester, MA
is a psychiatrist for the
Burn/Trauma Center at
Massachusetts General Hospital.
Jeffrey Morrison has opened a
new office on 5th Avenue in NYC
specializing in integrative
medicine and clinical nutrition.
Shelly Purvis and husband Rob
announce the birth of their 2nd
child, Kyle Jon, born July 8,
2004. After serving in the United
States Army for 7 years, Shelly
has resigned her commission.
They currently reside in Fort
Irwin, CA.
Theoklis Zaoutis of Ardmore, PA is
an Assistant Professor in the
Division of Infectious Diseases at
The Children's Hospital of
Philadelphia and the Department
of Pediatrics at the University of
Pennsylvania. He is also the
Director of Antimicrobial
Stewardship at CHOP. His research
interests are in the epidemiology of
fungal infections and nosocomial
infections in children. 
'97
Scott Cowan and Jennifer Tursi
Cowan '97 have moved to Boston.
Scott began a fellowship in thoracic
surgery and is at Massachusetts
General Hospital. Jennifer is an
internist with Harvard Vanguard
Medical Associates. Their son,
Scott Jr., is now one year old.  
Brian Devine has moved to
Charlotte, NC and opened an office
for Lakeside Family Physicians in
Highland Creek.
Christopher Doty is an Assistant
Professor at SUNY Downstate and
was recently made Director of the
Combined Emergency
Medicine/Internal Medicine
Residency Program at SUNY
Downstate and Kings County
Hospitals. He continues to serve as
Associate Program Director for the
Categorical Emergency Medicine
Residency there as well. He and his
wife, Beth, are living happily in
Brooklyn.
Al Girolamo and wife Heather of
Hopkinton, MA are proud to
announce the birth of their son
Hayden on August 20, 2004. Al is
an Assistant Professor of Clinical
Medicine at the University of
Massachusetts Medical School. He
is practicing general internal
medicine at a community health
center in Uxbridge, MA. 
Thomas Greidanus finished his
military commitment and
completed a residency in
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emergency medicine at the
University of Michigan,
graduating in June 2004. He is
currently on staff at Parkview
Medical Center in Pueblo, CO.
Matthew Wiesinger graduated
from Harbor-UCLA emergency
medicine. He married Tijen and
they have 2 boys. He works as a
partner at the Dominican
Hospital as a member of Santa
Cruz Emergency Physicians. The
family lives in Aptos, CA.
'98
Jonathan Harris of Bayside, NY is
enjoying practice in internal
medicine in the Bronx. He and
wife Dena are thrilled to
welcome the newest addition to
their family, Maxwell, who was
born July 22, 2004.
Andrew Lehman recently
completed his fellowship in hip
and knee reconstruction at the
Hospital for Special Surgery in
NYC. He has taken a job at New
England Orthopaedic Surgeons
in Springfield, MA where he is
subspecializing in hip and knee
replacements. He and his wife,
Heather, are also pleased to
announce the birth of their first
child, Alexander, in November
2004.
Patrick Mooney is the President
and CEO of Aphton Corporation,
a biotech company based in
Philadelphia. He lives in
Haddonfield, NJ with his wife,
Liz, and their 3 children.
G. Vike Vicente has completed
his fellowship in pediatric
ophthalmology at Boston
Children's Hospital and is
enjoying a private practice in
Bethesda, MD. He and wife
Wendy were delighted to
welcome their first child, Mark,
on February 27, 2004.
'99
Alynn Bosshard Alexander and
husband Chuck of Brick, NJ
announce the birth of their 2nd
child, John Tyler, on September
24, 2004. His sister, Brooke, is
now 3. Alynn is currently in
private practice with Brielle
Obstetrics and Gynecology in
Manasquan, NJ.
Stephanie Houser Caterson
married E. J. Caterson MD PhD
'03 in Lehighton, PA. She has
completed her general surgery
residency at TJUH and has
started her plastic and
reconstructive surgery fellowship
at the Lahey Clinic in Boston. 
Pia Fenimore and husband have a
new little boy, George Boben
Fenimore, born October 26. He
joins 3-year-old big brother
William. They are enjoying their
life in Lancaster, PA, and Pia is
practicing pediatrics in a very
busy private practice. 
Kern Singh is currently
completing his spine surgery
fellowship at Emory University
in Atlanta, and has already
accepted a staff position at Rush
University Medical Center in
Chicago. 
'00
Michael Baumholtz will finish a
general surgery residency in
York, PA this year and is looking
forward to hand surgery at Baylor
University in Houston for '05-'06.
Correction: Jonathan Salvin of
Rockville, MD was inadvertently
omitted from the Annual Giving
report in the last issue. Jonathan
continues to be a faithful
supporter of the medical college.
'01
Elizabeth Fagan of Summit, NJ
finished her residency in June,
and gave birth to daughter
Caitlin at the end of the same
month. Elizabeth is now a faculty
member for the Mountainside
Family Practice Residency in
Verona/Montclair, NJ.
Gregory Freimer has finished his
residency and started practicing
emergency medicine in Houston.
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When Renwick Hood ’81, a busy
ob/gyn in suburban Atlanta,
shows a visitor to a seat in his
booklined study, it is not to just
any seat. It is to an old, carved
student desk, proudly polished,
and bearing brass plaques with
the words “Jefferson Medical
College of Philadelphia” and
“Daniel Baugh Institute of
Anatomy.”
It is one of 2 identical desks that
Ren’s family—of whom he is the
11th member to attend
Jefferson—preserved from the
old “DBI,” which had its home at
11th and Clinton Streets, just
south of the present campus.
When Jefferson’s anatomy
facilities were incorporated into
the new Jefferson Alumni Hall
constructed in the late 1960s,
the old “DBI” was converted into
condominiums. But an identi-
fying stone plaque is still visible
today on the original dark-red
brick building with big windows
and white trim.
Any Jefferson grad from the
sixties or earlier will remember
“that” DBI, where the entire
starry-eyed freshman medical
class was introduced to the
shocks and wonders of
anatomical dissection. The
institute, an integral part of the
medical college, had been
outfitted through the generosity
of Daniel Baugh, an industrialist
and trustee in the early 20th
century who was an extraordi-
narily munificent donor.
Jefferson’s art collection includes
a portrait of Baugh and also 2
other paintings in which DBI
itself is depicted. In the Jefferson
Archives are old black-and-white
photos of dissections next to the
tall windows overlooking
Clinton Street.
The other historic desk
preserved in Ren’s family is kept
by his father, Christopher Hood
’54, at his home in Charlotte,
NC. But these proud DBI
graduates are only the latest in a
remarkable dynasty: inscribed
upon the desks are the names of
all 11 members of their family
who were affiliated with
Jefferson as alumni or faculty:
John W. Hood (1826)
Joseph T. Hood (1865)
Richard F. Hood (1865)
Marcellus A. Renwick (1867)
Spencer C. Graves (faculty)
John P. Kennedy (1915)
William M. Kennedy (1928)
Leon T. Kennedy (1935)
Christopher K. Hood (1954)
Charles A. Porter (1966)
Renwick C. Hood (1981)
The Legacy of DBI Continues
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In August 2004, Judd Moul ’82
was appointed the Professor and
Chief of Urologic
Surgery at Duke
University Medical
Center in Durham,
NC after a compre-
hensive national
search. Only the 4th
Chief of Urology
since the founding of
Duke in 1930, Judd
is heading up a
division of over 100
people that is
currently ranked 7th
in the U.S. News and World
Report annual rankings. Dr. Moul
is currently creating the new
DukeProstateCenter (DPC). 
Dr. Moul credits his Jefferson
experience with giving him a
strong foundation upon which to
build his medical career, and for
initiating his love of urology.
Upon graduation from residency
at Walter Reed Army Hospital,
Judd was asked to stay on at
Walter Reed as a staff urologist.
In 1988, he went to Duke where
he was an Army-sponsored fellow
in urologic oncology and became
involved in prostate cancer
research. 
After this fellowship, Judd was
hired as an Assistant Professor of
Surgery at the Uniformed
Services University of the Health
Sciences (USUHS) in Bethesda,
MD. In the early 1990s when
prostate cancer and the PSA test
received greater awareness, Dr.
Moul had the
opportunity to
help operate upon
and care for some
of the most
powerful men in
Washington.
Working with his
longtime mentor
and colleague Dr.
David McLeod,
Judd cared for
Senators Bob Dole,
Ted Stevens, and
Richard Shelby, as well as General
Norman Schwarzkopf. Through
these efforts, as well as public
advocacy, the U.S. Congress
mandated the formation of the
Department of Defense Center for
Prostate Disease Research in
1992. Judd was named its
Director, and developed and led
an internationally recognized
multidisciplinary team of
researchers and caregivers. The
CPDR program includes a
multicenter prostate research
database, a genetic discovery
program, and a clinical care and
clinical trials center at Walter
Reed Army Medical Center. 
During his tenure, the program
grew from a few individuals to a
dynamic program of over 80
persons at multiple locations,
conducting true state-of-the-art
work and being recognized with
top notch publications. Judd’s
work during this time included
the discovery that African
American men had higher PSA
values than white men, and his
development of better screening
guidelines for prostate cancer in
this population. This work was
published in JAMA and the New
England Journal of Medicine. 
Other prominent work included
large molecular biomarker
studies of p53, ras, bcl-2, Ki-67,
HER-2/neu, and others in
localized prostate cancer and a
series of articles on biochemical
recurrence of prostate cancer
that set the early standards for
this emerging clinical entity.
During his career in
Washington, Judd was very
involved in the prostate cancer
support group and advocacy
movement, being a charter
professional member of US TOO
International and being awarded
a national community service
award from the AMA for this
work. 
In July 2004, Moul retired from
the Army with 26 years of
service as a full Colonel, prior to
heading back to Duke. He was
honored with an endowed chair
being named in his honor—the
Judd W. Moul Distinguished
Chair in Prostate Science at
USUHS. 
C L A S S  N O T E S
Judd Moul ’82 Is Duke's New Chief of Urology
Research at the University of
Pennsylvania.
'03
Andrew Brown is currently in
his 2nd postgraduate year of
internal medicine at Columbia-
Presbyterian Medical Center. He
is applying for a fellowship in
hematology/oncology.
Michael Ward of Cleveland
Heights, OH completed his
transitional internship at St.
Barnabas Medical Center in
Livingston, NJ; he married his
college sweetheart, Megan, in
May 2004; and he is currently in
the first year of an ophthal-
mology residency at Case
Western Reserve University.
Postgraduate
Joseph De Santis GS'89 is
thriving as a plastic and
reconstructive surgeon at
Geisinger Medical Center. He
resides in Danville, PA with his
wife, Jeanne, and 3 children. 
Judith Lightsey RO'90 has joined
the faculty of the University of
Florida, Shands Cancer Center
in the Department of Radiation
Oncology. "Enjoying Gainesville
very much."
Donna Scott PD'93 of Rose
Valley, PA is the Director of
Inpatient Pediatrics at Crozer-
Chester Medical Center in
Upland, PA.
Michael Steinberg IM'97 is the
Medical Director of the UMDNJ
Tobacco Dependence Clinic. He
has 2 children and lives in
Princeton, NJ.
Michael Ramjattansingh R'99
was married on August 14, 2004
to Dorothy Cieniewicz. They
were married at the Hotel
duPont in Wilmington. He is a
practicing radiologist and
Dorothy is a sonographer. They
both live and work in Lewes,
DE.
David McCulley started a
neonatology fellowship at UCSF
after finishing his pediatrics
residency at the University of
Vermont.
Ryan Neff is enjoying life with
his new wife, Meghan. They were
married August 6 under the
Gateway Arch in St. Louis, MO
and are now homeowners in
Wilmington, DE. 
Nieta Green Shapiro recently
married, and is living in Wayne,
PA. She completed her internal
medicine residency at Fletcher
Allen Health Care in Burlington,
VT and is currently a hospitalist
at Pottstown Memorial Medical
Center.
Steve Wing of Perrysburg, OH is
practicing emergency medicine
in Toledo. He and his wife,
Rebekah, have 3 children.
'02
Kelly Liang of Rochester, MN will
be starting a nephrology
fellowship at the Mayo Clinic in
July 2005, and Kimberly Liang
will begin a rheumatology
fellowship there.
Christopher Smolock, after
completing 2 years of a general
surgery residency, commenced a
research fellowship in the
Harrison Department of Surgical
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Your gift to Jefferson can 
return payments to you for life. 
"You don't know what will happen 
next. I wanted to insure my future 
while,at the same time, provide a 
donation for Jefferson." 
Fred Teichmann, MD, JMC '78 
Deferred gift annuities provide 
immediate and long-term tax benefits . . . 
1 Gift of Property 
• You transfer cash, securities or other property 
to Jefferson. 
• Beginning on a specified date in the future, 
Jefferson begins to pay you, or up to two 
annuitants you name, fixed annuity 
payments for life. 
DONOR 
• The principal passes to Jefferson when the 
contract ends. 
Benefits to Y 
• An immediate income f 
deduction for a portion of your gift 
• Annuity payments can be postponed 
until you need them 
• The longer you defer payments, the 
higher the rate of return 
• Your significant gift now benefits 
both you and Jefferson later 
2 Income Tax Deduction Now 
Fixed Income Beginning Later 
Want to know more? Visit us at 
www.jefferson.edu/jeffgiving, call 
877-533-3443, or email Paul Hurd at 
plannedgiving@jefferson.edu. 

